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ABSTRACT  
   
The Western Pattern diet has been characterized by having greater than 50 percent 
consumption coming from fat and sugar. This macronutrient allocation has been shown to 
have deleterious effects on endothelial function and metabolic markers of cardiovascular 
disease. Exercise has been shown to improve vascular reactivity and metabolic markers 
related to cardiovascular health. The objective of the study was to determine if exercise 
training can prevent the anticipated deleterious effects of a fat-sugar supplemented diet 
on endothelial function and blood markers of cardiovascular risk in young men.  Twenty-
one, healthy college-aged males were randomly assigned to either the doughnut + 
exercise or doughnut only groups.  Both groups were fed 2 doughnuts per day, 6 days per 
week, for three weeks, while maintain their current diet.  The exercise group completed 4 
exercise training sessions per week consisting of 2 high intensity interval training bouts 
(up to 95% VO2peak) on a cycle ergometer and two moderate intensity, steady-state 
bouts (at 75% VO2peak) on a treadmill.  Changes in body weight and composition, 
markers of endothelial function, oxidative stress, serum lipids, and blood glucose were 
measured in each group.  As expected, cardiovascular fitness increased significantly in 
the doughnut-supplemented + exercise group as compared to the doughnut-supplemented 
(p=0.005). Significant increases in body weight (p=0.036), fat mass (p=0.013), and body 
fat percentage (p=0.014) were seen in the doughnut only group as compared to the 
doughnut + exercise group.  The doughnut + exercise group showed significant 
improvements in fasting serum triglycerides (p=0.036), plasma insulin (p=0.039) and 
insulin sensitivity (HOMA; p=0.05) as compared to the doughnut only group.  The 
doughnut + exercise group saw a significant improvement in nitric oxide availability 
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whereas the doughnut only group experienced a significant decline (p=0.014).  There 
were no significant changes in other markers.  Despite the addition of a fat/sugar 
supplement of ~11,600 kcal over three weeks, 4 exercise sessions per week were 
sufficient to prevent a gain in body weight and fat mass, and also improve some measures 
of cardiometabolic risk.  These results suggest that exercise may be necessary to prevent 
some adverse health outcomes associated with transient periods of excessive energy 
consumption.  
iii 
ACKNOWLEDGEMENTS 
I would like to extend my deepest gratitude to my mentor, Dr. Glenn Gaesser, for 
the constant encouragement and valued counsel he provided throughout my doctorate 
experience.  There were plenty of challenges that presented themselves during my time in 
the PANW program but no matter how many times I lost focus I could rest assured that 
getting back on track was just an email away – your patience with me was unswerving.  
Thank you for having faith in my ability to finish and being there when I found that faith 
in myself. 
To the rest of my committee, thank you.  Each of you played an integral part in 
successfully completing my dissertation.  You were selected professionally out of respect 
for the mastery you have in your field and personally because of your willingness to help 
guide me through the dissertation process.  I have gained so much from the input that 
each of you offered and I am so grateful for each of your contributions.  The time that 
you dedicated as a member of this committee will never be forgotten. 
You have all been invaluable during my time at ASU.  I appreciate all of you very 
much and would be more than happy to ever return the favor of support and service that 
you have so graciously shown me. To my lab colleagues, I could not have done this 
without you.  The time and effort that you put in to helping make the research happen 
was essential to my finishing.  I could not have asked for a more cohesive and welcoming 
group to come into when I returned to complete my research.  Individually, your insight 
and expertise really challenged me to be a better student, researcher and colleague.  It is 
my hope that you too find such gratification in the time you spend pursuing your degree 
while at ASU. 
iv 
TABLE OF CONTENTS 
 Page 
LIST OF TABLES ................................................................................................................. vii  
LIST OF FIGURES .............................................................................................................. viii 
CHAPTER 
1    INTRODUCTION ............................................................................................... 1  
Objective .......................................................................................................... 7  
Hypothesis ........................................................................................................ 7  
Delimitations .................................................................................................... 7  
Assumptions ..................................................................................................... 8  
Limitations ....................................................................................................... 8  
2    REVIEW OF LITERATURE ........................................................................... 10 
Diet vs. Exercise Debate ................................................................................ 12  
Vascular Function and Markers Cardiovascular Disease ............................. 13 
Pathology of Endothelial Dysfunction .......................................................... 14  
High Fat Diets ................................................................................................ 16  
High Sugar Diets  ........................................................................................... 21  
Exercise and Cardiovascular Disease ............................................................ 24  
Acute vs. Chronic Adaptations to Exercise ................................................... 24  
High Intensity Interval Training .................................................................... 27  
Interaction of Diet and Exercise .................................................................... 30  
3    METHODS ........................................................................................................ 36  
Experimental Sujects ..................................................................................... 36  
v 
CHAPTER  Page 
Study Design .................................................................................................. 36 
Measurements ................................................................................................ 39  
Statistics .......................................................................................................... 42   
4    RESULTS .......................................................................................................... 44  
Subject Characteristics ................................................................................... 44  
Dietary Intake ................................................................................................. 44  
Aerobic Fitness and Body Composition Changes ........................................ 47  
Endothelial Function & Markers of Oxidative Stress ................................... 50  
Serum Lipids & Blood Glucose .................................................................... 50  
5     DISCUSSION ................................................................................................... 55  
Body Composition ......................................................................................... 56  
Glucose and Insulin ........................................................................................ 59  
Endothelial Function ...................................................................................... 63  
Cardiovascular Risk Factors .......................................................................... 64 
Conclusions .................................................................................................... 68 
Strengths and Weaknesses ............................................................................. 69 
REFERENCES  ..................................................................................................................... 71 
APPENDICES  
A    INSTITUTIONAL REVIEW BOARD APPROVAL ..................................... 85 
B    IRB MODIFICATION 1 ................................................................................ 101  
C    IRB MODIFICATION 2 ................................................................................ 104 
D    SUBJECT RECRUITMENT FLIER ............................................................. 107 
vi 
E    CONSENT FORM .......................................................................................... 109  
F    DOUGHNUT MENU ..................................................................................... 116 
G    STATISTICAL ANALYSIS OUTPUT ........................................................ 118  
H    SUBJECT DATA ........................................................................................... 135  
 
 
  
vii 
LIST OF TABLES 
Table Page 
1.      Subject Demographics ....................................................................................... 45 
2.      Dietary Intake ..................................................................................................... 46 
3.      Cardiovascular Fitness & Body Composition  .................................................. 48 
4.      Endothelial Function .......................................................................................... 52 
5.      Blood Markers of Cardiometabolic Risk ........................................................... 53 
 
  
viii 
LIST OF FIGURES 
FIGURE Page 
1.      Change in Body Weight  .................................................................................... 49 
2.      Individual Change in Fat Mass .......................................................................... 51 
1 
Chapter 1 
INTRODUCTION 
The Western Pattern diet, popular in many developed countries, is characterized 
by high intakes of red meat, sugary desserts, high-fat foods, and refined grains.  
Commonly included in this diet is also a large consumption of high-fat dairy and sugar-
sweetened beverages.  More than 50 percent of all calories consumed in America come 
from fat and sugar.  There currently exists a plethora of research studies that confirm the 
deleterious effects of both high-sugar and high-fat diets on endothelial function and 
metabolic markers of cardiovascular disease (Nicholls et al., 2006; Johnson et al, 2009).   
Over the last ten years new evidence has emerged regarding the relationship 
between intake of sugars and cardiovascular disease (Ceriello et al., 2002).  The shift in 
dietary priority from nutritional value to convenience specifically over the past 40 years 
has been marked by a 19% rise in added sugars and an average intake of 22.2 grams of 
sugar per day (Johnson et al, 2009).  This average consumption equates to 355 
kilocalories per day which is well above the US Dietary Guidelines for discretionary 
calories consumed per day of 100 kilocalories for women and 150 kilocalories for men 
(US Department of Health and Human Services, 2005).  It is well supported that 
individuals with diabetes have an increased risk for cardiovascular disease; however, 
there are some studies that suggest that postprandial hyperglycemia and 
hypertriglyceridemia in nondiabetics are also independent risk factors for developing 
cardiovascular disease (Ebenbichler et al., 1995).   
In addition to a rise in sugar consumption, convenience-based dietary selections 
have also brought about an increase in the amount of saturated and trans fat consumed 
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(although regulations have reduced consumption of trans fat in recent years).  According 
to an executive summary conducted by researchers from the US Department of 
Agriculture, the average American consumed 85 grams of fat per day, comprising 35 
percent of their daily caloric intake.  In the Women’s Health Initiative (WHI) randomized 
clinical trial, reduction of total fat consumption from 37.8% energy to 24.3% energy (at 1 
year) and 28.8% energy (at 6 years) had no effect on incidence of heart disease, stroke, or 
total cardiovascular disease over a mean of 8.1 years (Howard et al., 2006).  This 
suggests that the role of dietary fat itself in cardiovascular disease may not be as 
important as generally thought.  A major limitation of the WHI study is that vigorous 
exercise, enough to improve cardiorespiratory fitness, was not part of the intervention.  
There is evidence to suggest that exercise and/or cardiorespiratory fitness may be more 
important than diet for reducing cardiovascular disease risk (Heroux & Janssen, 2010; 
Huffman et al, 2012; Kouki et al, 2012).   
In the Aerobics Center Longitudinal Study, high cardiorespiratory fitness in men 
and women was associated with low mortality risk regardless of diet quality (Heroux & 
Janssen, 2010).  In the Dose Response to Exercise Training Study, metabolic syndrome 
risk was influenced more by cardiorespiratory fitness than by diet (Kouki et al, 2012).  
For example, prevalence of metabolic syndrome was more than twice as high in persons 
with the healthiest diet but with low cardiorespiratory fitness as compared to persons with 
the unhealthiest diet score but a high cardiorespiratory fitness level.   Furthermore, in the 
Study of Targeted Risk Reduction Intervention through Defined Exercise, significant 
improvements resulting from exercise training were independent of diet quality (Huffman 
et al, 2012).  
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These studies are supported by a number of acute exercise studies demonstrating 
the beneficial effects of exercise in ameliorating the deleterious effects of a high-fat or 
high-sugar meal (Tyldum et al., 2009; Weiss, Arif, Villareal, Marzetti, & Holloszy, 2008; 
Padilla, Harris, Fly, Rink & Wallace, 2006).  In a 2009 study, Tyldum and colleagues 
examined the effects of continuous moderate intensity exercise and high intensity interval 
exercise on endothelial function following a high fat meal.  Before consuming the high-
fat meal, researchers had the participants perform a single bout of exercise (continuous 
moderate intensity or high intensity interval) the day before.  Approximately 16 hours 
after the exercise both the moderate and high intensity sessions improved endothelial 
function by 20%,( p < 0.01) and by 45% (p < 0.01) respectively.  However, after 
consuming the high fat meal, the high intensity interval exercise had not only prevented 
the normal decline in postprandial endothelial function, but brought about an increase in 
flow mediated dilation from baseline despite the high-fat meal-induced lipemia as 
compared to the continuous moderate intensity exercise and control groups.  Results from 
this study found that the efficacy of exercise on mitigating negative effects was intensity 
dependent.   Similarly, Weiss et al (2008) found that a single session of endurance 
exercise performed the day before consuming a high-sugar meal (candy bar and a sugar-
sweetened soft drink) was sufficient to attenuate the impairment in endothelial function 
that occurred after ingestion of the high-sugar meal without exercise.  In addition, the rise 
in postprandial plasma glucose and insulin concentrations was diminished, thus 
improving the insulin sensitivity index.   
One unresolved issue is whether these acute exercise results can be extended to a 
more sustained exercise setting (e.g., over weeks) in which the diet is altered to increase 
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fat and sugar consumption on a daily basis.  Short-term (i.e., 2 weeks) high-intensity 
exercise training that significantly improves cardiorespiratory fitness is effective in 
ameliorating the negative effects of postprandial hyperglycemia.  In 2011, Little and 
colleagues examined the effects of six exercise sessions of ten  one-minute intervals at 
90% of maximal heart rate on blood glucose regulation.  Following the interval exercise 
training protocol, there was a significant reduction in 24-hour glucose concentration from 
7.6 ±1.0 to 6.6±0.7 mmol/l (p<0.05) as well as 3-hour postprandial combined area under 
the curve (AUC) for breakfast lunch and dinner (pre: 11,066±1,703 vs. post: 9,572±995 
mmol·l-1·day-1, p<0.02). 
Also, endothelial function improvements with exercise training appear to be 
maximized after just 2 to 4 weeks of training (Tinken et al, 2008).  Because adverse 
effects of dietary changes can be observed within weeks (Silbernagel et al, 2011), it 
would be important to establish whether regular exercise could mitigate the anticipated 
deleterious effects on cardiovascular risk that could be expected during a short-term 
dietary intervention that increased fat and sugar consumption without overtly attempting 
to alter other dietary habits.   
The mechanism for exercise related improvement on endothelial function despite 
conditions of lipemia may be the result of various mechanisms.  Tyldum et al (2009) 
demonstrated that the improvement in endothelial function during the postprandial period 
was significantly correlated with total antioxidant capacity of the blood, with high-
intensity interval exercise having the most potent effect.  Though this explanation is 
merely one theory, this would suggest that the benefits maintain a link to NO 
bioavailability.   
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The connection between antioxidant status and NO bioavailability is supported by 
studies in which super-physiologic NO levels were induced by supplementing a high fat 
meal with sublingual nitroglycerin.  In this case, there were no deleterious effects on 
endothelial-dependent vasodilation following the intake of a high fat meal (Xu et al., 
2011).  Counterevidence to this theory has been shown through other exercise studies that 
suggest that acute exercise increases the circulation of free radicals in the blood which 
would inhibit the activation of nitric oxide subsequently resulting in a decline of vascular 
reactivity (Benjma & Ji, 1999; Bailey et al., 2003; Bailey et al, 2007).  Researchers in this 
particular study compared the improvement in endothelial function to that seen in studies 
where antioxidants prevented post-prandial endothelial dysfunction when given 
concurrently with a high fat meal (Plotnick, Corretti & Vogel, 1997). 
In effort to further understand the mechanisms behind exercise induced 
improvements in endothelial function despite a high fat diet, Park et al (2012) conducted 
a study on rats evaluating a number of different markers associated with cardiovascular 
health risk.  Three groups of rats were studied, differing in diet and exercise status: low-
fat sedentary, high-fat sedentary, and high-fat running.  The rats in the high-fat group 
were fed a diet comprised of 45% fat.  After 10 weeks, the high-fat sedentary group had 
decreases in acetylcholine (ACh)-induced and flow-induced vasodilatations in isolated, 
pressurized coronary arterioles, heart phosphorylated endothelial nitric oxide synthase (p-
eNOS/eNOS) protein, coronary arteriole leptin (ob) receptor protein, phosphorylated 
signal transducer and activator of transcription 3 (p-STAT3/STAT3) protein, and 
coronary arteriole superoxide dismutase 1 protein in comparison to the high-fat running 
group.  Additionally, the high-fat sedentary group had increases in percentage body fat, 
6 
serum leptin, coronary arteriole suppressor of cytokine signaling 3 (SOCS3) protein, and 
coronary arteriole gp91phox protein.  The results from this study suggest that there are a 
number of possible mechanisms responsible for the ability of exercise to attenuate or 
abolish any deleterious effects of a high-fat diet on cardiovascular health.  
Unfortunately, there is a lack of studies in humans investigating the magnitude of 
effect that exercise may play in maintaining vascular endothelial function despite a 
sustained increase in fat and sugar consumption.  The results of the few studies 
examining the ability of exercise to ameliorate or abolish the negative effects of a high-
fat or high-sugar diet are equivocal, and the potential mechanisms remain largely 
unknown.  The elevation in total antioxidant capacity in the blood as a result of a single 
exercise bout may explain the preservation of vascular function during a single 
postprandial setting, but no studies have been published to address whether this 
relationship extends to habitual diet conditions.  Therefore, the objective of this 
dissertation research is to determine whether regular exercise can prevent deterioration in 
vascular function expected to occur as a result of an increased consumption of fat and 
sugar during a three-week period in college-aged men, and to determine whether this is 
related to changes in antioxidant capacity, nitric oxide availability, and other established 
blood biomarkers of cardiovascular risk. 
Objective 
The objective of the study is to determine if exercise training can prevent the 
anticipated deleterious effects of a fat-sugar supplemented diet (in the form of two 
doughnuts per day, 6 days per week, for 3 weeks) on endothelial function and blood 
markers of cardiovascular disease risk.   
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Hypotheses 
H1:  
Fat-sugar supplemented diet will impair endothelial function and result in a 
worsened cardiovascular risk profile as assessed by fasting blood lipid profile, 
glucose, insulin, nitric oxide, total antioxidant capacity, and C-reactive protein. 
H2:  
Exercise training will prevent deleterious effects of a fat-sugar supplemented diet 
on markers of cardiovascular risk. 
Delimitations 
 This study is delimited to male participants between the ages of 18-30 that are 
generally sedentary, but otherwise metabolically healthy.  There are no weight 
requirements for this study.  Participants will be excluded from this study if they are 
currently involved in any form of regular aerobic exercise.  Current dietary intake will 
not be considered for participant selection but will be required to remain consistent 
throughout the entirety of the study.  Once enrolled in the study participants will not be 
permitted to participate in any form of aerobic activity outside of the protocol required 
for the experimental group to which they are assigned. 
Assumptions 
 It is assumed that the participants will comply with the testing protocol outside of 
the lab.  Following proper calibration protocols, the safety, proper use, and accuracy of 
all testing instruments is assumed.  Honesty is assumed on the part of the participant to 
uphold the integrity of the study instructions to: 
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o Abstain from exercise greater than what is needed for performing 
activities of daily living (ADL) during the 3 weeks of testing. 
o Refrain from making any alterations to their normal diet during the testing 
period. 
o Come to the lab in a fasted state (10 hours or overnight) prior to testing 
day only consuming water. 
Limitations 
The number of subjects in our study will be small but sufficient to reach statistical 
power for the primary (endothelial function) and secondary (plasma lipids) measure.  All 
participants will all be healthy college-age males, and it is not known whether the present 
training protocol will give similar adaptations in other populations such as women or 
subjects with cardiovascular disease.  A large dietary fat-sugar load will be utilized in this 
investigation. Although meals with this amount of fat and sugar are frequently consumed, 
the effects of the consumption of three weeks of a fat-sugar supplemented diet may not 
be reflective of a consistently high fat-sugar diet.  While it appears reasonable to assume 
that changes in vascular reactivity due to acute high-fat-sugar supplementation are 
transitory in nature, the longevity of the enhancement will not be measured in the current 
study. This study will not directly assess the effects of training on insulin sensitivity 
using hyperinsulinemic-euglycemic clamps and therefore cannot conclude whether low-
volume HIT improves muscle insulin sensitivity with accuracy beyond the HOMA 
calculations. 
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Chapter 2 
REVIEW OF LITERATURE 
Cardiovascular disease (CVD) is the leading cause of death in the U.S., 
accounting for approximately 810,000 deaths annually (Johnson et al, 2009). Many risk 
factors for CVD such as diabetes, obesity, and smoking are associated with increased 
oxidative stress and inflammation, suggesting that these responses are involved in the 
initiation and pathogenesis of CVD.  Because of the strong association between oxidative 
stress and vascular health, it is important to examine the mechanisms that regulate 
vascular endothelial function and define dietary strategies that can attenuate the oxidative 
stress responses that modulate these mechanisms.   
A number of studies have shown that weight-related health conditions are 
significantly improved with just modest amounts of weight loss if they are brought about 
by increases in physical activity (NIH, 1998).  Though over seventy percent of 
Americans have reported trying to lose weight at least once in the past 4 years, very few 
use the approach of moderate calorie reduction and an increase in physical activity.  A 
meta-analysis examining the nutrient breakdown of popular diets did a comparison 
against the typical American diet.  The typical American diet consists of 2200 total 
calories, 35 percent from fat, 50 percent from carbohydrates, and 15 percent from protein 
(Freedman, King, & Kennedy, 2001).  
Contributing to the typical American diet is fast food, a 165 billion dollar industry 
in the US alone.  The increased intake specifically in energy and saturated fat has been a 
large contributor to the increased risk of cardiovascular disease related to regular fast 
food consumption.  In an effort to assess the effects of fast food consumption on vascular 
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function and markers of cardiovascular disease, Rudolph and colleagues (2012) evaluated 
items of various nutrient contents (burger and fries, vegetarian burger and fries, 
vegetarian burger and side salad) on healthy individuals.  Results from this study showed 
a significant decrease in FMD after all meals but no significant different between meals.  
The results of this study show that there was no benefit to consuming the arguably 
healthier vegetarian burger or side options to the traditional beef burger and French fries 
in respect to vascular reactivity. 
The western pattern diet (high intakes of red meat, processed eat, refined grains, 
french fries, and sweets/desserts) has been evaluated in comparison to a prudent pattern 
diet (high intakes of vegetables, fruit, legumes, fish, poultry, and whole grains) in a 
number of studies.  Based on data from the Nurses’ Health Study, researchers concluded 
that the western pattern diet was associated with a higher risk of morality from 
cardiovascular disease (22%), cancer (16%), and all-causes (21%) (Heidemann et al., 
2009).  What these results do not address is the role of cardiovascular fitness in 
mitigating these risks.  Heroux and colleagues (2010) conducted an analysis of risk 
similar to the aforementioned review while controlling for self-reported physical activity 
levels.  In agreement with the previous review these researchers identified the group at 
greatest mortality risk as the highest quintile of the Unhealthy Eating Index 
(characterized by a higher intake of red meat, added fat and simple carbohydrates, and a 
lower intake of non-citrus fruits).  The 40% higher mortality risk associated with the 
lowest quintile of Unhealthy Eating Index was reduced by 55% after controlling for 
cardiorespiratory fitness.  In fact, within the highest quintile of cardiorespiratory fitness, 
mortality risk was unrelated to Unhealthy Eating Index score.  The implications of this 
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review suggest that cardiorespiratory fitness level, presumably achieved in large part 
through regular exercise, may offset much of the risk associated with unhealthy dietary 
patterns.  
Diet vs. Exercise Debate 
There is an ongoing debate as to whether exercise or nutrition plays a greater 
impact on protecting against cardiovascular disease risk.  In 2010, Kouki and colleagues 
conducted a study aimed at examining the individual and combined effects of diet and 
exercise on the prevalence of metabolic syndrome.  Dietary assessment was done via a 
four day food log specifically looking at intake of vegetables, fiber, and fish as well as 
the percentage of total energy consumption from saturated fatty acids.  Cardiorespiratory 
fitness levels were assessed using a maximal cycle ergometer test.  Results from the study 
indicated that individuals in the highest VO2max tertile and who met 3-4 dietary goals 
had the lowest prevalence of metabolic syndrome (5%)   In contrast, individuals meeting 
the least number or dietary goals and scoring in the lowest tertile of fitness had the 
highest prevalence.  The results also indicate that fitness levels are a stronger predictor of 
metabolic syndrome and not even a healthy diet can diminish the risk of low fitness 
levels.  To examine this further Huffman et al (2012) conducted an exercise study in 
sedentary individuals while analyzing dietary patterns.  After evaluating total fat, 
saturated fat, trans fatty acids, cholesterol, omega-3 fatty acids, and fiber researchers 
looked at the adjusted risk for heart disease.  The results from this study revealed that 
independent of diet, exercise had beneficial effects on low density lipoprotein, high-
density lipoprotein, cholesterol molecule size, and triglycerides (P < 0.05).  
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A review of the current literature as taken the diet versus exercise debate and 
looked into the development of coronary artery disease and vascular function (Taylor, 
2012).  In two similar studies, researchers established two cohorts of animals which were 
fed either a control or obesogenic high-fat diet for 10 weeks, and a third cohort that was 
allowed to voluntarily exercise by having access to running wheels as a ‘primordial 
prevention’ strategy, coinciding with the imposition of the high-fat dietary regimen 
(Booth & Lees, 2006; Park et al, 2012).  In the sedentary group, high-fat feeding over 10 
weeks in adult female mice produced a 4-fold increase in fat mass and in serum leptin 
concentration compared to low-fat controls, which was prevented by concomitant 
voluntary physical exercise; mice ran a remarkable 17.5 km per day on average.  Diet-
induced obesity was associated with profound impairment of endothelium-dependent 
relaxation to acetylcholine and flow-mediated dilatation in isolated coronary arterioles.  
The impairment in endothelium-dependent relaxation, which was nitric oxide dependent 
and associated with a reduction in eNOS phosphorylation, was entirely prevented by 
voluntary exercise and the absence of obesity despite on-going consumption of the high-
fat diet.  These results would appear to suggest that the presence of obesity rather than the 
high-fat diet per se is the predominant risk factor for coronary artery endothelial 
dysfunction. 
Vascular Function and Markers of Cardiovascular Disease 
The vascular endothelium is a thin layer of cells situated on top of the smooth 
muscle and lines the interior surface of the blood vessels located between cellular 
elements in the bloodstream and vascular smooth muscle cells in the blood vessel wall.  
The endothelium acts as a sort of biophysical sensor that holds the ability to respond to 
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changes in both the physical and metabolic environment to maintain vascular 
homeostasis.  Its main purpose is to regulate the passage of substances from the 
bloodstream to the vascular wall.  
The healthy endothelium is an important regulatory organ in maintaining 
cardiovascular homeostasis by controlling the balance between several opposing forces, 
including vasoconstriction and vasodilation, growth promotion and inhibition, pro-
coagulation and anticoagulation, pro-inflammation and anti-inflammation, and oxidation 
and anti-oxidation; all of which, if unbalanced, would contribute to atherogenesis 
(Zabinski, Saelens, Stein, Hayden-Wade & Wilfley, 2003; Deforche, De Bourdeaudhuij 
& Tanghe, 2006; Nassis et al, 2005).  Pioneering experiments by Furchgott and Zawadzki 
(1980) showed that the presence of an intact endothelium is essential for acetylcholine 
(ACh) to activate endothelium derived relaxing factors which allows for dilation of the 
arteries (Alexander, Landsman, Teutsch & Haffner, 2003). 
Pathology of Endothelial Dysfunction 
Impairments in normal functioning of the vascular endothelium have been shown 
to be an early indicator of atherosclerosis and future cardiovascular disease (CVD) risk 
(Zabinski, Saelens, Stein, Hayden-Wade & Wilfley, 2003). While alterations in 
endothelial function are multi-factorial, many mechanisms implicated in the pathogenesis 
of VED, such as formation of atherosclerotic plaques, are related to increased oxidative 
stress.   
Vascular homeostasis is centrally regulated by vascular endothelial cells by 
modulating biological processes such as blood vessel formation, coagulation and 
fibrinolysis, vascular tone and inflammation (Deforche, De Bourdeaudhuij & Tanghe, 
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2006). Endothelial cells respond to both circulating factors such as hormones and 
mechanical changes due to blood flow. The mechanical forces that regulate endothelial 
cells include blood pressure, the hydrostatic forces of blood within the blood vessel; and 
shear stress, the dragging frictional force created by blood flow. The nature of shear 
stress plays an important role in the maintenance of proper vascular function and 
cardiovascular health (Deforche, De Bourdeaudhuij & Tanghe, 2006). In fact, laminar 
shear stress, generated by blood flowing in a stable laminar pattern, is generally regarded 
as atheroprotective whereas the development of atherosclerosis is largely attributed to 
turbulent blood flow (Nassis et al, 2005). Greater laminar shear stress induces the release 
of endothelium-derived relaxing factors such as nitric oxide and acetylcholine. 
While endothelial dysfunction is most often thought of as an impairment of 
endothelium-dependent vasodilation, it most likely also includes impairments in other 
endothelial dependent functions. The nature of endothelial dysfunction resulting in 
attenuation of NO-mediated responses is unclear, however several likely mechanisms of 
endothelial dysfunction include: alterations in signal transduction, reduced availability of 
L-arginine, modification of the expression of eNOS, altered availability of cofactors for 
eNOS, imbalance between the production of endothelium-derived constricting and 
relaxing factors, increased destruction of NO by reactive oxygen species (ROS), intimal 
thickening as a diffusion barrier, and increased production of endothelium-dependent 
constricting factors (endothelin being the most prominent).  
Endothelial dysfunction has been shown to be present in a wide range of vascular 
disorders, including atherosclerosis, type 2 diabetes mellitus, and hypertension. It is 
thought that disruption of the functional integrity of the vascular endothelium plays an 
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integral role in all stages of atherogenesis ranging from lesion initiation to plaque rupture.  
In a prospective study by Schachinger and colleagues (2000), 147 consecutive patients 
underwent coronary endothelial function testing in response to several stimuli 
(acetylcholine, cold pressor test, flow-mediated dilation) and subsequently were followed 
for 6.7 years.  Patients who presented with endothelial dysfunction at the inception of the 
study had a significantly greater number of cardiovascular events.  Obesity is associated 
with both endothelial dysfunction and increased risk of CVD in older adults; therefore it 
could be hypothesized that a similar relationship would be found between these variables 
in adolescents and young adults as well.  While the mechanisms that lead to obesity-
caused endothelial dysfunction remain unclear, it is thought that both insulin and a 
chronic pro-inflammatory state play a critical role. 
High Fat Diets 
The physiologic impact of dietary fat is well established.  In one of the earlier 
studies, Straznicky and colleagues (1993) compared the effects of either a high-fat or 
low-fat diet on blood pressure, cardiovascular reactivity and sympathetic activity.  In this 
case subjects were followed one of the two diets for 2 weeks.  After this time, heart rate, 
mean arterial pressure, total plasma cholesterol and low-density lipoprotein levels fell 
significantly in the low-fat diet group as compared to the high fat-diet group.  Since then, 
results from a number of studies in this area were summarized in a recent literature 
review assessing the effects of reducing or modifying dietary fat consumption on various 
measures of cardiovascular disease and acute cardiovascular incidence rates. This meta-
analysis suggested that modification of dietary fat intake in favor of increasing 
unsaturated fats rather than an overall reduction of dietary fats.  A compilation of the 
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clinical trials indicated that reducing saturated fat intake but not overall fat intake reduced 
risk of cardiovascular events by 14% (Hooper et al, 2012). 
That dietary fat quality (type) rather than total amount is more important for a 
number of health outcomes is highlighted by studyshowing that the consumption of 
saturated fat, but not unsaturated fat, impairs the anti-inflammatory properties of high-
density lipoproteins as well as endothelial function (Nicholls, 2006).  After the 
consumption of an isocaloric meal containing either polyunsaturated or saturated fats, 
researchers measured the impact on high-density lipoprotein inhibitory activity by 
assessing the rate of expression of intercellular adhesion molecule-1 (ICAM-1) and 
vascular cell adhesion molecule-1 (VCAM-1).  Flow-mediated dilation decreased at 3 
hours post saturated fat consumption (P < 0.05).  Interestingly, there was no significant 
post prandial difference in either group at 6 hours.  This suggests that post prandial 
changes in vascular reactivity may be acute.   
Though the effect of varying fat-subgroups has been documented, it is necessary 
to evaluate the level of dietary modification necessary to make an notable impact on risk 
reduction.  Astrup et al conducted a similar review of the effects of dietary modification 
on cardiovascular risk defining the necessary level of modification for a 2-3% reduction 
in risk consuming a Western diet as a replacement of 1% of energy from saturated fatty 
acids with polyunsaturated fatty acids (2010).  In contrast, conflicting studies have shown 
that many of the specific fatty acid subgroups do not have a significant influence on 
overall measures of cardiovascular health (Hu, Manson & Willett 2001).  Additional 
health discrepancies related to the type of fat ingested extends to inflammatory markers 
(Peairs, Rankin & Lee 2011).  What remain in question are the optimal dose of specific 
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fatty acids and the ability of certain fats to attenuate or negate the physiologic risks 
associated with elevated saturated fat consumption.  On the other hand, the effects of 
saturated fat intake on metabolic markers and cardiovascular reactivity are well 
documented.  
Vascular reactivity as determined by endothelial function is strongly effected by 
modifiable and non-modifiable (age, smoking, blood pressure and metabolic 
abnormalities) risk factors.  Of these factors, research has shown that dietary intake 
significantly influences metabolic abnormalities.  In agreement with this association, test 
meal studies have consistently shown that the consumption of a high-fat meal has 
detrimental effects on postprandial vascular function (Vafeiadou et al, 2012).  An early 
study by Vogel and colleagues (1997) took a closer look at the impact of diet on 
endothelial in healthy subjects.  Subjects were randomized into either a no-fat or high-fat 
meal group.  The high-fat group saw a detrimental change in triglycerides and flow-
mediated dilation at 2 and 4 hours post feeding (P < 0.05).  In addition to these changes, 
there was a correlation between the rise in triglycerides (2 hours) (but not low-density 
lipoproteins) and the decline in endothelial function.  This opens up the possibility that 
post prandial triglyceride levels may be one factor driving the change in flow-mediated 
dilation. 
There has been recent evidence to suggest that a high-fat meal may also have 
avenues of indirect impact on vascular reactivity.  High levels of saturated fat and 
cholesterol may contribute to increases in blood pressure through the development of 
plaques on vessel walls, which result in the reduction of both their diameter and 
elasticity.  Each of these measures is a critical element in evaluating endothelial function.  
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Jakulj and colleagues (2007) have shown that a high-fat meal may increase sensitivity to 
psychological stress in healthy adults.  In response to either a high-fat or low-fat feeding, 
systolic and diastolic blood pressure and total peripheral resistance were measured 
acutely following a variety of psychological stress tests.  Results showed a significant rise 
in each of the aforementioned measures from baseline in the low-fat group versus the 
high-fat group. 
One suggested mechanism by which this decline in vascular function occurs is 
through a disruption of the normal production of superoxide anions in the vasculature 
(Ross, 1999).  Superoxide anions are known to trigger vasoconstriction through a reaction 
with nitric oxide.  This reaction results in the production of peroxynitrite, a strong 
oxidizing agent that damages endothelial function.  
TNF-α, a proinflammatory cytokine has also been shown to induce an impairment 
of endothelium-dependent vasodilation in a variety of vascular beds by increasing 
oxidative stress and decreasing the release of nitric oxide (Boger, 2004). TNF- α may 
have a direct action on decreasing the amount of nitric oxide released and endothelium 
nitric oxide production. Further, it may directly activate NAD(P)H oxidase and increase 
reactive oxygen species production in vascular smooth muscle (Chen, Montagnani, 
Funahashi, Shimomura, Quon, 2003). TNF-α has a major role in adipose tissue and there 
is evidence of a three-fold increase in TNF-α mRNA protein and circulating levels in 
obese individuals. Winkler et al. (2002) showed that increased levels of TNF-α may be 
one of the linking factors in the insulin resistance and endothelial dysfunction 
relationship. 
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Adiponectin is a collagen-like plasma protein that is produced by the adipose 
tissue and that is abundant in the systemic circulation. In response to a high-fat diet, 
plasma concentrations of adiponectin are decreased.  Adiponectin plays an important role 
in the regulation of insulin action, and has been shown to be positively correlated with 
insulin sensitivity. In addition to its effect on glucose metabolism, adiponectin appears to 
modulate endothelial function.  Adiponectin has been shown to stimulate production of 
NO (and suppress adhesion molecule expression in vascular endothelial cells.  In three 
recent clinical studies in adults, hypoadiponectinemia has been found to be directly 
correlated with endothelial function of the peripheral arteries (Ouchi et al, 2003; 
Shimabukuro et al, 2003; Tan et al, 2004). 
Serum antioxidant levels have recently been examined as a possible underlying 
cause of the oxidative stress-related impairments on endothelial function.  Following the 
ingestion of a high-fat meal, the antioxidant enzyme glutathione peroxidase, as well as 
the urinary excretion of 8-epi-prostaglandin F2α, were measured to assess the impact of 
serum antioxidants (Tsai, Li, Lin, Chao & Chen, 2004).  Though no changes were 
observed in high-sensitivity C-reactive protein and adhesion molecules, there was a 
decline in endothelial function.  Endothelial dysfunction was brought about in response to 
augmented oxidative stress incurred by the depletion of serum antioxidant enzymes and 
increased excretion of oxidative modification products. 
Research has also examined the mechanism behind the acute proatherogenic 
effect of back to back high-fat meal ingestions.  Tushuizen and colleges (2006) measured 
flow-mediated dilation as well as serum cholesterol levels after feeding healthy subjects 
two high-fat meals.  Following the second high-fat feeding researchers noted significant 
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impairment of flow-mediated dilation as well as increased oxidized low-density 
lipoprotein concentration.  Participants experienced a moderate rise in glucose and 
triglycerides following the feedings which remained just within the normal range.  
Although this may not be of concern for healthy individuals, the results may have 
important implications for individuals predisposed to heart disease or type II diabetes. 
High Sugar Diets 
An increase in sugar intake between 1970 and 2005 of approximately 20 percent, 
largely in response to the availability of added sugars and sugar-sweetened beverages, 
has demanded a greater look into the impact of sugar ingestion on the risk of obesity and 
cardiovascular disease.  Based on the 2005 US Dietary Guidelines, added sugars greatly 
exceeds discretionary calorie allowances regardless of energy needs.  The chronic excess 
of sugar has been linked with several metabolic abnormalities, adverse health conditions, 
and lack of essential nutrients.  Studies have suggested that factors such as meal 
composition, method of food preparation and physiological factors influence the impact 
of sugar on the body’s glucose response and overall health (McDonald et al, 1995; Chen, 
Halter, Porte, 1987; Modghaddam, Vogt, Wolever, 2006).  Sucrose and fructose tend to 
increase postprandial triglycerides and very low density lipoprotein levels, which may 
augment lipemiaalso appear to be common abnormalities in a diet high in added sugars 
(Chong, Fielding, Frayn, 2007; Teff et al, 2004).  Inconsistent results on the effects of 
different monosaccharides on lipid levels suggest that more research is needed to 
investigate the mechanism of action (Silbernagel, 2011).  Studies have shown that a high 
consumption of high-sugar foods and beverages and foods is associated with evidence of 
increased inflammation and oxidative stress (Lui et al, 2002; Price, Price, Reynolds, 
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2001; Scribner, Pawlak, Ludwig, 2007).  Though the exact mechanism(s) by which sugar 
intake is associated with these negative factors is not known, the resultant elevated risk 
for cardiovascular disease has been well documented.   
Overwhelming research indicates that oxidative stress induced by postprandial 
hyperglycemia, which may be induced by a high-sugar diet in healthy individuals has 
been shown to occur concomitantly with vascular endothelial dysfunction.  While the 
exact mechanisms causing endothelial dysfunction remain unclear and incompletely 
explored, insulin resistance and the presence of proinflammatory markers are two likely 
candidates.  Insulin resistance classically refers to an impairment of the degree to which a 
given quantity of insulin lowers plasma glucose.  Data now show that insulin resistance is 
associated with endothelial dysfunction and insulin sensitivity is inversely proportional to 
the development of atherosclerosis.  Petrie et al. (1996) showed a close positive 
relationship between insulin sensitivity and basal endothelial NO production.  There is a 
well-established relationship between reactive oxygen species (ROS) and NO.  
Hyperglycemia is associated with the generation of ROS.  NO has a direct effect on 
oxidative stress by scavenging ROS, and NO inactivation is enhanced in the presence of 
excess ROS.  An overproduction of ROS may injure the endothelial cell membrane, 
inactivate NO, and cause oxidation of BH4. 
 Evidence exists to suggest that high-sugar or high-fat intake individually impairs 
endothelial function.  Additional studies have examined the possible cumulative effect of 
hypertriglyceridemia and hyperglycemia on endothelial function (Ceriello et al, 2002).  
Participants underwent 3 feedings: a high-fat load, high-sugar load, and a combined load.  
Following the combined load there was a decrease in flow-mediated dilation and a rise in 
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nitrotyrosine that was more pronounced than either high-fat or high-sugar feedings alone.  
The rise in nitrotyrosine would support the theory that oxidative stress is the common 
mediator of endothelial dysfunction. 
There is an established association between insulin and leptin as regulators of 
appetite and weight.  Insulin is a trigger for leptin, both of which are transported to the 
central nervous system where they interact with neuropeptides in the hypothalamus that 
are known to impact food intake.  Studies have shown a reduction in both insulin and 
leptin levels following the consumption of high-fat meals despite sufficient energy 
consumption (Havel et al, 1999; Romon, Lebel, Velly, Marecaux, Fruchart, 
Dallongeville, 1999).  Because low levels of leptin tend to stimulate an increase in 
appetite, it could be suggested that high-fat and/or high-sugar diets could promote weight 
gain by leading to excessive energy intake. 
Exercise and Cardiovascular Disease 
Evidence exists to suggest that high-sugar or high-fat intake individually impairs 
endothelial function.  Additional studies have examined the possible cumulative effect of 
hypertriglyceridemia and hyperglycemia on endothelial function (Ceriello et al, 2002).  
Participants underwent 3 feedings: a high-fat load, high-sugar load, and a combined load.  
Following the combined load there was a decrease in flow-mediated dilation and a rise in 
nitrotyrosine that was more pronounced than either high-fat or high-sugar feedings alone.  
The rise in nitrotyrosine would support the theory that oxidative stress is the common 
mediator of endothelial dysfunction. 
There is an established association between insulin and leptin as regulators of 
appetite and weight.  Insulin is a trigger for leptin, both of which are transported to the 
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central nervous system where they interact with neuropeptides in the hypothalamus that 
are known to impact food intake.  Studies have shown a reduction in both insulin and 
leptin levels following the consumption of high-fat meals despite sufficient energy 
consumption (Havel et al, 1999; Romon et al, 1999).  Because low levels of leptin tend to 
stimulate an increase in appetite, it could be suggested that high-fat and/or high-sugar 
diets could promote weight gain by leading to excessive energy intake. 
Acute vs. Chronic Adaptations to Exercise 
Results from previous exercise studies suggest that chronic exercise results in 
improved endothelial function. Endothelium-dependent responses of the brachial artery in 
young healthy men were improved after just ten-weeks of regular physical exercise 
training at a moderate intensity (Clarkson et al., 1999).  Another 12-week exercise 
program improved endothelial function in patients who had metabolic syndrome, but who 
were otherwise asymptomatic for cardiovascular disease (Lavrencic, Salobir, & Keber, 
2000).  Another recent study showed that endurance-trained men did not demonstrate an 
age-related decline in endothelium-dependent vasodilation (Tounian et al, 2001).  The 
results in this study demonstrated that both middle aged and older men who regularly 
perform aerobic exercise exhibited greater acetylcholine-mediated vasodilation than their 
sedentary counterparts.  Additionally, regular aerobic exercise restored the loss of 
endothelium-dependent vasodilation in previously sedentary middle aged and older men. 
In this case, patients with documented coronary artery disease showed an improvement in 
coronary endothelial function after just four weeks of vigorous exercise training.  The 
latter results suggest an upregulation of the eNOS gene in response to chronic increases 
in shear stress and blood flow brought about by exercise. 
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In evaluating endothelial function, the time course of change has proven to be a 
key component in vascular adaptation.  Studies show that approximately two to three 
weeks of training is optimal to identifying changes in endothelial function.  This is in part 
due to the physical increase in vessel diameter that appears as a result of chronic exercise 
training.  In 2008, Tinken et al theorized that short-term exercise training enhances eNOS 
and nitric oxide bioactivity and chronic exercise training induces arterial remodeling 
resulting in an increase in arterial size (Delp et al.1993; Sessa et al. 1994; Sun et al. 1994; 
Delp & Laughlin,1997; Brown, 2003; Prior et al. 2003).  In effort to take a closer look at 
the chronological changes in vascular structure and function in response to exercise 
training their study examined conduit artery flow mediated dilation and conduit dilator 
capacity at two week intervals over the course of an 8 week training intervention.  Results 
revealed increases in flow mediated dilation from baseline (5.9±0.5%) to 2 weeks 
(9.1±0.6, P <0.01) and 4 weeks (8.5±0.6%, P <0.01) but a return toward baseline at 6 
and 8 weeks.  In contrast, brachial artery dilation capacity progressively increased 
significantly (P <0.05) from baseline (8.1±0.4%) at weeks 2 (9.2±0.6), 4 (9.6±0.6%), 6 
(10.0±0.5%), and 8 (10.5±0.8%).  These results suggest that functional changes in 
vascular health preceded physical adaptations of arterial remodeling. 
It is well accepted that chronic cardiovascular exercise can ameliorate the 
negative effects of an unhealthy diet.  Additionally, it has also been established that a 
high-fat meal causes significant post-prandial impairment of endothelial function.  With 
this additional knowledge, it is necessary to solidify the effects of a single bout of 
exercise on the acute physiologic response to a high fat meal.  Padilla and colleges (2006) 
examined this question by conducting a 3-condition study (low-fat meal, high-fat meal, 
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high-fat meal + exercise) and measuring 4-hour post prandial flow-mediated dilation.  
FMD was significantly elevated above pre-prandial values following the high fat meal + 
exercise (5.61±1.54 to 8.72±0.94%, P = 0.005) but was unchanged following the LFM 
(6.17±0.94 to 7.18±1.31%, P = 0.317) and the HFM (5.73±1.23 to 4.29±1.64%, P = 
0.160). These findings suggest that a single aerobic exercise session cannot only 
counteract the postprandial endothelial dysfunction induced by the ingestion of a high-fat 
meal, but also increase brachial artery FMD in apparently healthy adults.   
In addition to acute changes in vascular reactivity in response to exercise training 
regardless of feeding scenarios, research also shows an improvement in post-prandial 
lipemia.  In an acute exercise study utilizing sprint interval cycling, participants 
experienced 3 testing conditions – exercise with no energy replacement, exercise + 
energy replacement, and control (Freese et al, 2011).  Participants performed exercise one 
evening either maintaining an energy deficit or feeding for energy balance before a 13-
hour overnight fast.  The following morning participants had baseline venous samples 
taken (insulin, glucose, cholesterol, triglycerides) and were fed a high-fat meal after 
which researchers monitored blood levels at 0, 30, 60, 120, 180 minutes.  The 
postprandial area under the curve (mmol·l-1·3h-1) triglyceride response was significantly 
lower in energy deficit (21%, P < 0.006) and energy balance groups (10%, P < 0.044) 
than in control, and significantly lower in energy deficit (12%, P < 0.032) than in the 
energy balance group. The energy deficit created by exercise plays an important role in 
the reduction in post prandial, suggesting that delaying replacement of the energy used 
during exercise has important health benefits. The results from this study support the 
growing literature  indicating that the physiological effects and health benefits of high-
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intensity, low-volume exercise are similar to those of moderate-intensity, high-volume 
exercise training. 
High Intensity Interval Training 
Increasing interest has risen in the benefits of high-intensity interval training in 
decreasing risk of cardiovascular disease.  In 2008, Perry et al conducted study to identify 
the ability of high-intensity aerobic interval training to influence the carbohydrate and fat 
oxidation capacity in skeletal muscle as well as whole-body metabolic adaptations.  
Participants performed 10x4 minute intervals at 90% VO2peak separated by 2 minutes of 
active rest three times a week for 6 weeks.  To examine changes in oxidation capacity 
researchers collected muscle biopsies at rest, after 5 minutes of a maximal exercise test, 
and at exhaustion.  Adaptations during exercise included reduced glycogenolysis, lactate 
accumulation, and substrate phosphorylation (0–5 min of total expenditure), unchanged 
carbohydrate oxidation, and approximately 2-fold greater time to exhaustion; and 
increased fat oxidation at 60% of pre-training VO2 peak. This study demonstrated that 3 
sessions per week of repeated high-intensity exercise over 6 weeks is an effect method to 
increase whole-body and skeletal muscle capacities to oxidize fat and carbohydrate in 
previously untrained individuals. 
Sufficient evidence has long existed to support the efficacy of endurance training 
on incurring cardiac adaptation ultimately leading to a reduction of cardiovascular risk.  
The challenge that remains is the identification of the changes at the cellular level that 
beget these adaptations.  In 2009, Wisloff and colleagues conducted a study to test 
whether a dose response effect of training on cardiac response exists in regards to training 
intensity.  During training participants performed four, 4-minute intervals at 90-95% 
27 
VO2peak separated by three minutes of active rest.  In comparison to participants who 
performed continuous exercise at 70% VO2peak, the high-intensity interval group made 
significant improvements in general cardiovascular health markers such as, left 
ventricular remodeling, ejection fraction and endothelial function as a result of training.  
These results suggest that improvements in cardiovascular function in response to 
exercise may be dose dependent as related to intensity. 
Similar research studies have taken a different look at the benefits of interval 
training on metabolic indices related to metabolic syndrome.  Little and colleagues 
(2011) also sought to determine if high-intensity training would have a comparable if not 
superior effects on hyperglycemia and mitochondrial capacity than commonly prescribed 
endurance training with despite reduced exercise volume.  Participants in this study 
performed ten, 1-min intervals on a cycle ergometer at 90% HRmax separated by 1 
minute of active rest three times per week for 2 weeks.  Average 24-h blood glucose 
concentration was reduced after training (7.6±1.0 vs. 6.6±0.7mmol/l) as well as post-
prandial area under the curve (P<0.05).  Training also increased muscle mitochondrial 
capacity as evidenced by higher citrate synthase maximal activity (20%) and protein 
content of Complex II 70 kDa subunit (37%), Complex III Core 2 protein (51%), and 
Complex IV subunit IV (68%, all P<0.05). Mitofusin 2 (71%) and GLUT4 (369%) 
protein content were also higher after training (both P <0.05).  Results show that low-
volume, high-intensity training can effectively control blood glucose levels and improve 
metabolic capacity of skeletal muscle. 
A recent study by Goto and colleagues (2003) examined the effects of different 
intensities of exercise on endothelium-dependent vasodilation in humans.  Subjects (26 
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healthy males) were randomly assigned to one of three training groups: mild intensity (25 
percent VO2 max), moderate intensity (50 percent VO2 max), or high intensity (75 
percent of VO2 max) (2003).  Results showed that twelve weeks of moderate-intensity 
exercise, but not mild- or high-intensity exercise, significantly increased acetylcholine-
induced vasodilation of the brachial artery.  Both 8-hydroxy-2’-deoxyguanosine and 
serum concentrations of mallondialdehyde-modified low-density lipoprotein were 
measured to evaluate the amount of oxidative stress present in each group.  Both indices 
of oxidative stress were increased in the high-intensity group after exercise, whereas in 
the moderate-intensity group both were decreased after the exercise training.  Those 
subjects that trained at a low-intensity had neither increased oxidative stress markers nor 
any improvements in endothelial function.  These findings suggest that moderate-
intensity aerobic exercise successfully augments endothelium-dependent vasodilation, 
while high-intensity exercise increases oxidative stress that may interfere with an 
increased production of nitric oxide. 
Interaction of Diet and Exercise 
When examining the effects of exercise on physiologic markers of health it is 
necessary to also consider the interaction effects of dietary intake.  Though research has 
provided some insight into contributing factors such as impaired endothelial function and 
reduced flow-mediated vasoactivity, the exact physiological mechanisms responsible for 
the effect of dietary feedings on cardiovascular function are still largely unknown (Tsai, 
Li, Lin, Chao, & Chen, 2004; Vogel, Corretti, & Plotnick, 1997).  Earlier animal studies 
provided some preliminary data on these changes.  In a study looking at mice exposed to 
high-fat or low-fat feedings over the course of twelve weeks, researchers examined the 
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effects of exercise on metabolic indices (Duggan, Hittel, Sensen, Weljie, Vogel, Shearer, 
2011).  Each feeding group was further divided into exercise or non-exercise conditions.  
After analyzing metabolites significantly changing in response to the high-fat feeding, 
results showed that exercise was able to mitigate most but not all of the negative effects 
of the high-fat diet.   
In effort to bridge the knowledge gap to human subjects, Faulk & Bartholomew 
aimed to reexamine the effects of consuming a high-fat meal on cardiovascular reactivity 
while controlling for protein content and to determine if acute exercise can moderate the 
impact of dietary fat consumption on cardiovascular reactivity (2012).  Participants were 
grouped into either high- or low-fat diets and further into exercise or no exercise.  Results 
from this study indicated that consumption of a single high-fat meal may lead to increases 
in mean arterial pressure, however a single bout of high-intensity exercise can mitigate 
rises in both mean arterial pressure and heart rate reactivity.   
In 2009, Tyldum and colleagues took a closer look at the effects of both exercise 
and high-fat meals on endothelial function.  Brachial artery flow-mediated dilation was 
assessed in healthy men before and after a high fat meal after one of three conditions: an 
extended rest, a single bout of continuous moderate-intensity exercise, and high-intensity 
interval exercise.  Prior to consuming the high-fat meal, researchers found an 
improvement in flow-mediated dilation in the continuous moderate-intensity exercise 
(+20%, p<0.01) and the high-intensity interval exercise (+45%, p<0.01).  After this 
exercise session participants consumed the high-fat meal that had previously been shown 
to impair flow-mediated dilation at baseline.  Post prandial endothelial function was 
assessed at 30, 120, and 240 minutes and compared to baseline.  Across these time points, 
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exercise was able to mitigate the decline in flow-mediated dilation.  In contrast to the 
continuous and control group the high-intensity group exhibited a sustained elevation in 
endothelial function despite postprandial lipemia. 
Diets specifically high in saturated fatty acids have been shown to have 
deleterious effects on metabolic markers and increase cardiovascular disease risk in 
otherwise healthy individuals.  In response to these previous findings, a recent study has 
looked at the ability of aerobic exercise to mitigate these effects (Oretga et al, 2013).  All 
participants in this study increased saturated fat intake from 31±10 to 52±14 grams per 
day for two weeks while maintaining total fat intake.  One-half of the participants also 
underwent 11 cycle-ergometer sessions of 55 minutes at 60% of VO2peak, while the 
other half remained sedentary.  As compared to baseline, there were no changes in body 
weight, composition, plasma free fatty acids, and insulin sensitivity.  In contrast, the 
researchers did find an increase in total cholesterol (147±8 to 161±9 mg/dL-1, P =0.018) 
and low-density (71±10 to 82±10 mg/dL-1, P = 0.034) in the diet only group. 
At the cellular level it is uncertain as to whether increasing dietary fat availability 
after exercise alters the exercise-induced increase in insulin sensitivity.  Several studies 
have also associated insulin resistance with an accumulation of triglycerides within the 
muscle cell (Goodpaster, Thaete, Simoneau, and Kelly, 1997; Oakes et al, 1997; Pan et 
al, 1997), but the direct effect of IMTG concentration of insulin sensitivity remains 
unknown (Furler et al, 2001; Hegarty, Fuler, Ye, Coone, & Kraegen, 2003). Researchers 
investigated whether adding fat calories to meals after exercise alters glucose tolerance 
the next day (Fox, Kaufman & Horowitz, 2004). Healthy men cycled 90 min at 66±2% 
peak oxygen uptake followed by a maximum of five high-intensity intervals. Following 
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the exercise, participants ingested three meals containing either low-fat (5% energy from 
fat) or high-fat (45% energy from fat) foods.  Muscle biopsies taken 24 hours after 
exercise revealed an increase (~20%) in intramuscular triglycerides in the high-fat group.  
Regardless of the rise in intramuscular triglycerides, there was no difference in glucose 
tolerance between groups.  
Mixed findings regarding the relationship between carbohydrate metabolism and 
lipid levels have driven efforts to identify the mechanisms at the cellular level that may 
explain physiological responses to high fat feedings.  To accomplish this, more recent 
research has focused on intramyocellular lipids.  While consuming both a high-fat and 
low-fat feeding during two separate 5 week periods during a crossover training study, 
healthy subjects performed time trials on a cycle ergometer as well as a completing a half 
marathon (Vogt et al, 2003).  Despite a significant ~2-fold rise in intramyocellular lipids 
during the high-fat feeding period, muscle glycogen stores were maintained.  Findings of 
these two studies suggest the inverse relationship between intramyocellular concentration 
and insulin sensitivity may only exist in sedentary subjects (Goodpaster et al, 1997; 
Oakes et al, 1997). 
As discussed in previous studies, responses to high-fat feedings may vary by body 
composition as well as activity level.  In young, metabolically healthy males, researchers 
examined the effect of prior exercise on postprandial triglycerides, insulin, glucose, and 
inflammatory markers (MacEneaney et al, 2009).  Participants were grouped by body 
mass index.  On two different occasions each participant underwent a 6 hour oral fat 
tolerance test following either an exercise bout or in a rested state.  Exercise was shown 
to reduce postprandial triglyceride area under the curve by 20 percent (p<0.01).  There 
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were no significant changes in glucose, insulin or inflammatory markers between normal 
weight and overweight participants.   
To better evaluate the effect of exercise on postprandial markers of glucose and 
insulin, it is necessary to consume a comparable load of glucose to that which was given 
in the high-fat trials.  Weiss and colleagues (2008) sought to determine whether 
endurance exercise performed 17 hours before high-sugar ingestion attenuates 
postprandial impairment of endothelial function.  Data for flow-mediated dilation, 
glucose, insulin, and thiobarbituric acid-reactive substances, a marker of oxidative stress, 
were collected from all participants to assess change from before to after the ingestion of 
a candy bar and a soda.  In both rested and exercised states, there was a significant 
decrease in flow-mediated dilation following high-sugar ingestion, however there was a 
significant shift creating a greater area under the curve in the previously exercised group 
(P = 0.01).  Prior exercise brought about similar improvements in the areas under the 
curve for both glucose (P = 0.05) and insulin (P = 0.0007) as well as significant 
improvements in insulin sensitivity index (10.8±0.7, P = 0.01).  Results support the 
efficacy of exercise in glucogregulation independent of improvements in oxidative stress. 
In a trial looking at the aforementioned metabolic markers, Strohacker et al 
(2012) also evaluated the effect of a single pre-meal exercise bout on endothelial stress 
and inflammation following a high-fat meal.  Participants completed two trials, one 
resting and one moderate-intensity cycling bout prior to a high-fat feeding.  In agreement 
with previous research, Strohacker and colleagues observed no significant impact of 
premeal exercise on postprandial concentrations of triglycerides, total cholesterol, HDL 
cholesterol or glucose (MacEneaney et al, 2009).  Evaluation of the changes in monocyte 
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cell surface receptor expression as well as endothelial microparticles between groups 
revealed a significant group difference.  Moderate-intensity, premeal cycling successfully 
mitigated postprandial increases in the classic subset of monocyte cell surface particles 
CD18 (p=0.001) and CD11a (p=0.026).  Similarly, endothelial microparticle count was 
47% greater 3 hours post feeding in the resting, no-exercise condition (p≤0.05) than the 
pre-meal cycling condition.  Receptor expression and peripheral blood monocytes as 
those measured in this study may play prominent roles in inflammation and 
atherosclerosis.   
It has been established that in states of hyperlipidemia, oxidative stress, and 
vascular inflammation, monocytes affix to the endothelial lining which subsequently 
leads to macrophage accumulation and foam cell formation – a precursor to 
atherosclerosis.  The current pool of research has highlighted the need to further identify 
and understand the mechanisms by which exercise acts as a moderator of cardiovascular 
health.  The extrapolation of the findings in the aforementioned research to vascular 
function and markers of metabolic health is potentially critical in supporting the efficacy 
of exercise for the prevention of cardiovascular disease regardless of dietary intake.   
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Chapter 3 
METHODS 
Experimental Subjects 
Twenty-one (21) male subjects between the ages of 18 - 30 years old were 
recruited from Phoenix and surrounding areas for participation in this study (see 
Appendix D).  Eligible participants were generally sedentary (exercising less than 1 day 
per week), were in generally good health, had no restrictions for participating in vigorous 
intensity physical activity, and were not taking any medications for blood pressure, 
cholesterol, diabetes or a heart condition.  Volunteers were excluded from the study if 
they had a history of smoking, cardiovascular disease, renal or liver disease, were taking 
hypoglycemic and / or hypertensive medication, had been physically active for the 3 
months, or had any additional conditions that would be contraindicative of exercise.  The 
Institutional Review Board of the Arizona State University approved all methods and 
procedures. 
Study Design 
All participants who responded to the recruitment flyer were provided a copy of 
the consent form to read, and any questions they had about the study were answered by 
study personnel.  All aspects of the study were explained and written consent was 
obtained.  Participants filled out a physical activity readiness questionnaire (PAR-Q) to 
ensure that they were suitable candidates for enrollment.  If they answered “yes” to any 
of the questions, they were not allowed to participate.  If they answered “no” to each 
question, they were allowed to participate.  Those who decided to participate after 
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signing this consent form underwent a flow-mediated dilation (FMD) procedure (see 
below) to make sure a viable acoustic window of their brachial artery could be obtained. 
Participants who agreed to take part in the study reported to the Healthy Lifestyles 
Research Center in ISTB3 on the ASU Polytechnic Campus for all visits.  Participants 
randomly assigned to the doughnut-supplemented group were required to have 11 
additional visits beyond the screening visit (visits 2 through 12) over a 3-week period to 
pick up their doughnuts.  Participants randomly assigned to the doughnut-supplemented + 
exercise group participated in a total of 14 visits beyond the screening visit (visits 2 
thorough 15) over a 3-week period. Visits are described in detail below. 
Baseline Testing 
The participants reported for baseline testing at the ISTB3 building following an 
overnight fast (nothing but water after 10 PM). Participants first had a measurement of 
brachial artery flow-mediated dilation taken, followed by resting blood pressure 
measurement.  After two blood pressure readings, participants then had body composition 
assessed (BOD POD).  Following this measurement, participants had a fasting blood 
draw.  For the final test, all participants performed a VO2max test on a cycle ergometer to 
determine maximal oxygen uptake.  Participants were randomly assigned to either the 
doughnut-supplemented + exercise group or doughnut-only group. 
Visits 3 through11 (Doughnut-Supplemented Group) 
These visits were designated for picking up the doughnuts that were provided to 
each participant during the 3-week study.  Participants picked up bags of 4 fresh 
doughnuts each at the ISTB3 laboratory on Monday, Wednesday and Friday of each 
week. 
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Visits 3 through14 (Doughnut-Supplemented + Exercise Training Group)  
The participants in the doughnut-supplemented + exercise training group reported 
to the ISTB3 building for exercise training.  Participants trained four (4) days per week 
for three (3) consecutive weeks.  Training sessions were not required to occur on 
consecutive days.  All exercise training were performed on either a motor-driven 
treadmill (continuous exercise sessions) or a cycle ergometer (interval and/or continuous 
exercise sessions).  The aerobic exercise training protocol consisted of 2 sessions/week of 
continuous exercise and 2 sessions/week of interval exercise.  The exercise protocols 
were as follows:  
• 2 days per week of continuous exercise: 30 minutes at a heart rate associated with 
75% maximum heart rate determined from the baseline cycle test. 
• 2 days per week of high-intensity interval exercise: 
• One day per week: Ten 1-minute intervals at 90-95% of maximum heart 
rate, separated by 1 minute of active recovery at 60% of maximum heart 
rate (Little et al, 2011). 
• One day per week: Four 4-minute intervals at 90-95% of maximum heart 
rate, separated by 3 minutes of active recovery at 60% of maximum heart 
rate (Wisloff et al, 2009). 
Each exercise session was preceded by a 5 minute warm-up (50-60% of maximum heart 
rate), and concluded with a 5-minute cool-down (50-60% of maximum heart rate). 
Final Visit (Visit 12 for Doughnut Only Group; Visit 15 for Donut-Supplemented + 
Exercise Training Group)  
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Approximately 48 hours following the last training session, the participant 
reported to the ISTB3 building following a 10 hour (overnight) fast.  Post-test 
appointments were scheduled within 1 hour of time of day of baseline testing to avoid 
error due to diurnal variation of some of the measurements.  Participants first had 
brachial artery flow-mediated dilation measured, followed by 2 measurements of resting 
blood pressure.  After two blood pressure readings, participants then had body 
composition assessed (BOD POD).  Following this measurement, participants had a 
fasting blood draw.  All participants finished testing with a VO2max test on a treadmill to 
determine maximal oxygen uptake.   
Measurement 
Brachial Artery Flow Mediated Dilation (BAFMD) 
This is a non-invasive assessment of the ability of the brachial (upper arm) artery 
to dilate in response to an increase in blood flow, and is assessed using ultrasound.  This 
procedure is performed while the subject is lying supine on a padded ultrasound table.  
All measurements are made on the non-dominant arm.  A blood pressure cuff is 
positioned on the subject’s forearm, midway between the elbow and wrist.  After 
recording baseline ultrasound measures on the upper arm, the blood pressure cuff is 
inflated to 250 mmHg for 5 minutes.  The cuff is then deflated rapidly and brachial artery 
blood flow and arterial diameter are measured continuously for 5 minutes using the 
ultrasound probe.  Ultrasound images were acquired using a Terason t3000CV ultrasound 
system (Terason Ultrasound, Burlington, MA) equipped with an 11-3L linear array 
transducer.  FMD is calculated as the percentage increase in diameter from baseline to 
peak diameter, where baseline diameter was the average diastolic diameter over the 2-
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min baseline, and peak diameter was recorded as the 10-s average of the highest diastolic 
diameter after cuff deflation.  These procedures conform to the published guidelines of 
the International Brachial Artery Reactivity Task Force (Corretti et al, 2002).   
Blood Draw 
Subjects were asked to report for each blood draw (visits 2 and 12 for doughnut 
only group; visits 2 and 15 for doughnut + exercise training group) in the morning 
following an overnight fast (i.e., nothing but water after 10 PM).  Intravenous blood was 
drawn via one of the common antecubital fossa veins (cephalic, median cubital, or basilic 
vein) for measurement of blood lipids, glucose, insulin, and antioxidant capacity.  All 
blood draws were performed by a certified phlebotomist.  Approximately 15ml (3tsp) of 
blood were collected for each blood draw.  Blood will be analyzed for plasma lipids, 
glucose, insulin, C-reactive protein, nitric oxide availability, and total antioxidant 
capacity.  Plasma was isolated and stored at -80 °C for later analysis.   
Glucose was analyzed by using the glucose oxidase method.  Serum lipids were 
assessed by using a cholesterol fluorometric assay kit (Cayman Item No. 10007640).  The 
assay is based on an enzyme-coupled reaction that detects both free cholesterol and 
cholesterol esters.  Nitric Oxide was analyzed by using a nitrate/nitrite flurometric assay 
(Cayman Item No.780051).  This assay measures total nitrate/nitrite concentration by 
converting nitrate to nitrite and then measuring the fluorescence of 1(H)-naphthotriazole.   
Antioxidant capacity was assessed through a serum assay (Cayman Item No. 709001).  
The capacity of the antioxidants in the samples to prevent ABTS (2,2’-Azino-di-[3-
ethylbenzthiazoline sulphonate]) oxidation was compared with that of Trolox, a water-
soluble tocopherol analogue, and was quantified as millimolar Trolox equivalents.  High-
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sensitivity C-reactive protein was analyzed from serum samples using a sandwich 
ELISA, HRP-lablled antibody assay.  All samples were analyzed in duplicate, and all 
samples for each subject were batch analyzed to eliminate interassay variability.  Insulin 
will be analyzed using a double antibody radioimmunoassay.   The homeostasis model 
assessment of insulin sensitivity (HOMA) will be calculated as follows (Matthews et 
al,1985; Chen et al, 2005): 
HOMA = fasting glucose(mg/dL) * fasting insulin(µU/mL)/405 
Blood Pressure  
Resting blood pressure was measured using an automated blood pressure 
machine.  The patient was comfortably seated in a chair and the deflated cuff applied to 
the right arm just proximal to the elbow with the bladder centered over the brachial 
artery.  Proper cuff size was determined based on the standard recommendation that the 
bladder should be approximately 40% of the circumference of the limb tested 
(Brzezinski, 1990).  Pressure was then rapidly increased to at least 30 mmHg higher than 
that which eliminates a palpable radial pulse. 
Anthropometrics 
Subjects’ weight was measured on a standard Beam scale.  Height was assessed 
on a stadiometer.  
Body Composition 
Body composition was measured using a Bod Pod (air displacement 
plethysmography).  All participants were required to wear a swimsuit and swim cap 
during the BodPod test to minimize errors caused by air trapped in clothing and hair.  
Subjects were weighed prior to entering the BodPod, before sitting comfortably in the 
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measurement chamber.  The door was then closed and the run begins.  Each subject run 
took less than one minute.  If the two subject measurements did not agree, a third run was 
done. The two closest runs were then averaged.  Lung volume was estimated for each 
participant.  This completes the measurement procedure, and results for %fat and fat-free 
mass are displayed. 
VO2max test 
Subjects were equipped with a mask attached to flexible, low-resistance tubing, 
and Polar heart rate monitor for the metabolic measurement device (Parvo Truemax 
2400TM) to measure ventilation and respiratory gas exchange data and heart rate 
continuously.  After collecting resting data for 2 minutes, subjects pedaled on a stationary 
cycle ergometer at a cadence of their choice at 50 watts for 5 minutes for the warm-up 
phase.  After the warm-up phase, load was increased continuously by 30 watts/minutes 
every minute until the subject was unable to continue.  Verbal encouragement was given 
to all subjects throughout the entire test.  The highest oxygen uptake during the test was 
taken as the value for peak VO2.  
Fat-Sugar Dietary Supplement 
Each participant was required to consume 2 doughnuts per day, 6 days per week, 
for 3 weeks.  Doughnuts were purchased by the study researchers at a local Dunkin 
Donuts on Monday, Wednesday and Friday morning of each week.  Participants were 
required to come to the ISTB3 laboratory on Monday, Wednesday, and Friday of each 
week for doughnut pickup.  This could be part of the regular exercise training visits for 
those in the exercise training group.  On each occasion participants were given 4 
doughnuts to consume over the following two days.  This schedule was designed to 
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optimize compliance while ensuring that the doughnuts are fresh.  Participants were 
provided a menu of doughnut options so that each participant would be able to choose the 
types of doughnuts that he would like most to consume.  The menu was divided into three 
categories by energy content (250-299 kcal, 300-349 kcal, 350-399 kcal).  Participants 
were instructed to select 4 doughnuts from each category each week (totaling 12 per 
week) to minimize variance in consumption between participants.  All doughnuts contain 
between 260 and 400 calories, of which at least 70% of total calories were fat and sugar. 
Food Frequency Questionnaire (ASA24) 
The participants were required to complete the ASA24 recall at the beginning of 
the study to determine if dietary intake was homogeneous between groups at baseline.  
The ASA24 allows study participants to report their intake for the previous day from 
midnight to midnight.  The Respondent application guides the participant through the 
completion of a 24hour recall for the previous day from midnight to midnight using a 
dynamic user interface.  This application provides an animated guide to instruct 
participants and enhance use in low-literacy populations (with options to turn off the 
guide and/or the audio).  This program asked respondents to report eating occasion and 
time of consumption and includes optional modules to query about where meals were 
eaten, who the respondent ate with, and television or computer use during meals.  
Respondents were provided a meal-based "quick list" of foods and drinks consumed the 
previous day and were able to find foods or drinks to report by browsing food groups or 
searching from a list of food terms derived from USDA’s AMPM.  This program guided 
respondents through detailed questions about food preparation and additions to assigned 
food codes from USDA’s Food and Nutrient Database for Dietary Studies (FNDDS).  
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This program also uses images to assist respondents in reporting accurate portion size and 
allows the respondent to add or modify food and drink choices at multiple times.  The 
report developed form the information provided includes a final review of the day's 
intake for each participant. 
Daily Dietary Requirements 
Each participant was encouraged to maintain his normal diet as reported to the 
ASA24 diet recall during the three weeks, other than consuming the 2 doughnuts per day 
provided by study researchers as a requirement for participating in the study.  
Statistics 
Data were assessed to first determine normality status of testing groups in this 
randomized control-group pretest-posttest design.  Pre- and post-test comparisons were 
made, assuming no outliers and equal variances (Levene test), on blood pressure, blood 
lipids, glucose, insulin, insulin sensitivity, nitric oxide, hsCRP, total antioxidant capacity, 
and endothelial function.  Statistical analyses were performed using SPSS 13.0 for 
Windows.  Results are presented as the mean ± standard deviation with significance 
shown when p<.05.  An independent t-test was conducted to compare the delta values for 
each variable between the control and exercise groups.  An a priori power analysis was 
performed to determine the sample size necessary to detect significant changes in flow-
mediated dilation of the brachial artery.  It was determined that for a randomized control-
group pretest-posttest, in order to detect a large effect size (Cohen f = 0.5) (Cohen, 1988) 
in brachial artery flow mediated dilation with α = 0.05 significance level and power of 
>0.80 that sixteen (n=16) subjects would be needed to obtain statistical significance for 
this study (Tyldum et al, 2009).  Accounting for a 20 percent dropout rate, twenty (21) 
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subjects were recruited for this study.  Power calculations were performed using 
G*power 3.0 software (Faul, Erdfelder, Lang, Buchner 2007). 
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Chapter 4 
RESULTS 
Subject Characteristics 
A total of twenty-one (n=21) college-aged, males were recruited for this study.  
Participants range in age from 18 to 30 years (24 ± 3.4) and consisted of 60 percent 
Caucasian, 20 percent Hispanic, and 20 percent African American.  During the testing 
period, two subjects, one from each treatment group, were unable to complete the trial 
(one due to a scheduling issue and another due to a lack of transportation).  Thus, all data 
represent a total of 19 individuals.  No differences in age or BMI were found between 
groups at baseline.  There were also no significant differences in age, blood pressure, 
body fat percentage, or VO2peak (Table 1).   
Dietary Intake 
Based upon 24-hour dietary recall data there were no significant differences in 
baseline total kcal intake between the doughnut + exercise group and the doughnut only 
group (2499 ± 314 kcal/day) (p>0.05) (Table 2).  The two groups did not differ with 
regard to macronutrient intake based upon the results from the ASA24 24 hour recall 
questionnaire.   
All subjects successfully picked up their doughnuts, three times per week, during 
the study.  The total energy content of the three dozen doughnuts did not differ between 
doughnut + exercise (11,640 ± 225 kcal) and doughnut only (11,696 ± 134 kcal) groups. 
Additionally, total fat (688 ± 39 g vs. 679 ± 28 g), saturated fat (311 ± 19g vs. 305 ± 
17g), and sugar (153 ± 28 g vs. 145 ± 44 g) content of the three dozen doughnuts 
consumed did not differ between the doughnut + exercise and doughnut only groups 
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Table 1 
Subject Demographics 
    Baseline Measures 
Measure   
Doughnut  
+Exercise 
(n=10)    
Doughnut Only 
(n=9)   
Combined 
(N=19) 
Age (years) 23.1±2.42 25.0±4.15 24.0±3.39 
Weight (kg) 74.29±7.48 78.84±21.76 76.44±15.62 
Height (cm) 176.03±5.76 176.88±6.00 176.43±5.72 
BMI (kg/m2) 24.03±2.79 25.04±6.15 24.51±4.58 
Body Fat (%) 17.4±8.56 22.96±13.05 20.01±10.92 
Blood Pressure 
Systolic 122.0±7.98 124.00±7.63 122.94±7.67 
Diastolic 76.7±8.52 75.88±9.86 76.31±8.93 
VO2peak (L/min) 3.08±0.29 2.65±0.42 2.88±.414 
              
Results are reported as Mean ± Standard Deviation. 
Significance is set at p=0.05. 
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Table 2 
Dietary Intake 
    Baseline Measures 
Measure   
Doughnut 
+Exercise 
(n=10)  
Doughnut Only 
(n=9) 
Combined 
(N=19) 
Daily Intake 
Calories 2455±348 2499±314 2476±324 
Fat (g) 76±11 78±9 77±10 
Carbohydrates (g) 331±47 337±42 334±43 
Protein (g) 110±16 113±14 111±14 
Total Donut Intake 
Calories 11640±225 11697±134 11667±185 
Fat (g) 688±39 680±28 684±33 
Saturated Fat (g) 311±19 305±17 308±18 
Sugar (g) 536±46 528±41 532±42 
Daily Donut Intake 
Calories 645±13 650±7 647±11 
Fat (g) 38±2 38±2 38±2 
Saturated Fat (g) 17±1 17±1 17±1 
Sugar (g) 30±2 30±2 30±2 
          
Results are reported as Mean ± Standard Deviation. 
Significance is set at p=0.05. 
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 (p>0.05).Daily caloric intake from the donuts was not significantly different between the 
doughnut + exercise group (645 ± 13kcals) and the doughnut only group (650 ± 7kcals).  
There were also no significant differences in average daily intake of total fat, saturated 
fat, and sugar (p>0.05). 
Aerobic Fitness and Body Composition Changes 
Subjects in the doughnut + exercise training group significantly increased 
VO2peak after three weeks of training by ~7.8% (3.08 ± 0.29 L/min to 3.32 ± 0.29 
L/min), whereas the doughnut only group showed no change in aerobic capacity (2.65 ± 
0.42 L/min to 2.63 ± 0.44 L/min) (p = 0.005 between groups) (Table 3).  Subjects in the 
exercise training group completed all 12 supervised exercise sessions, accounting for 
100% adherence.  Based on baseline VO2peak and assigned training intensity, mean 
energy expenditure during exercise sessions was estimated to be 354 ± 22kcal per session 
at the start of training.  Due to the observed increase in VO2peak (~7.8%; or about 2.6% 
per week), the total estimated energy expenditure of the 12 training sessions was 
approximately 4,360 kcal per subject.  This corresponds to approximately 38% of the 
energy value of the three dozen doughnuts consumed over the course of the study. 
Changes in body weight, fat mass, and percentage body fat were all different 
between groups (Table 3).  Whereas body weight remained unchanged in the doughnut + 
exercise training group (Pre = 74.3 ± 7.5 kg; Post = 74.2 ± 8.9 kg), body weight increased 
in the doughnut only group (Pre = 78.8 ± 21.7 kg; Post = 80.5 ± 21.5 kg) (p = 0.036 for 
group differences) (Figure 1).  In the doughnut + exercise training group fat mass (Pre = 
13.6 ± 7.8 kg; Post = 13.4 ± 7.6 kg) and percentage body fat (Pre = 17.4 ± 8.6 %; Post =
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Figure 1.Change in Body Weight for the doughnut + exercise group versus the doughnut 
only group between baseline and post testing. Bolded line represents the group means for 
the doughnut + exercise  (-0.05±1.2kg) and doughnut only (1.7±2.0kg).  There was a 
significant interaction effect for body weight (p=0.036). 
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17.1 ± 8.3 %) did not change, in contrast to the doughnut only group which increased 
both fat mass (Pre = 21.2 ± 18.3 %; Post = 23.6 ± 18.9 %) (p = 0.013 between groups) 
and percent body fat (Pre = 22.9 ± 13.1 %; Post = 24.4 ± 12.7 %) (p = 0.014 between 
groups) (Figure 2).   
Endothelial Function and Markers of Oxidative stress 
Baseline and post-test values for endothelial function, baseline diameter, and peak 
diameter are shown in Table 4.  There were no significant differences in blood pressure 
or flow mediated dilation from baseline to post testing between the doughnut + exercise 
and doughnut groups.  There was a significant difference between the change in baseline 
diameter pre to post in the doughnut + exercise group (0.39±0.03 cm to 0.42±0.03 cm) 
(p=0.001) versus the doughnut only group (0.37±0.04 cm to 0.38±0.03 cm).  Additionally 
there was a significant difference in peak diameter in the doughnut + exercise group 
(0.41±0.03 cm to 0.43±0.03cm) (p=0.04) but not in the doughnut only group (0.39±0.05 
cm to 0.41±0.05 cm).  Results for high sensitivity C-reactive protein (hsCRP), nitric 
oxide (NO), and antioxidants (AOX) are shown in Table 5.  There was a significant 
change in nitric oxide availability between groups (-4.29 ± 3.39 uM vs. +4.33 ± 8.76 uM, 
p=0.014) in the doughnut only and doughnut + exercise groups respectively.  There were 
no significant differences in C-reactive protein or total antioxidant capacity between 
treatment groups. 
Serum Lipids & Blood Glucose 
Baseline and posttest values for serum lipids (total cholesterol (CHOL), low-
density lipoprotein (LDL), high density lipoprotein (HDL), triglycerides (TG)), fasting 
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Figure 2. Individual change in fat mass by group over time.  There was a significant 
difference in change in mean fat mass between the doughnut + exercise group (-0.2±1.2) 
and the doughnut only group (1.5±1.5) (p=0.013).
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glucose, insulin, and insulin sensitivity are shown in Table 5.  There was a significant 
difference in serum TG between the doughnut + exercise group (-16.0 ± 29.7 mg/dL) and  
the doughnut only group (15.1 ± 24.13 mg/dL) (p=0.036).  There were significant group 
differences in change in fasting insulin between the doughnut + exercise (11.1±3.7 to 
9.5±3.4 uU/ml) and doughnut group (9.6±2.9 to 11.6±5.9 uU/ml) (p=0.039).  Similarly, 
there was a significant improvement in insulin sensitivity, as calculated using the HOMA 
equation, between the doughnut + exercise (2.1±1.0 to 1.8±0.8) and the doughnut only 
groups (2.1±0.9 to 2.7±1.5) (p=0.05) though there was no significant change in fasting 
glucose between groups.  There were no significant differences in total cholesterol, LDL, 
HDL within subjects or between groups in this study.    
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Chapter 5 
DISCUSSION 
In this study, exercise training 4 days per week, including 2 days of high-intensity 
interval exercise and 2 days vigorous-intensity, steady-state exercise, were utilized to 
examine the efficacy of exercise to ameliorate the expected undesirable health effects of a 
fat-sugar supplemented diet in otherwise healthy, college-aged males.  Following three 
weeks of sustained overfeeding of approximately 600 calories per day, 6 days per week, 
in the form of doughnuts, exercise prevented weight gain and an increase in body fat.   
The results on cardiovascular risk markers were mixed, largely due to the fact that the 
donut-supplemented diet did not negatively impact most blood markers examined in the 
control group. 
It was hypothesized that the consumption of three dozen doughnuts over 3 weeks 
would adversely impact cardiometabolic risk markers, and that the regular exercise 
sessions would prevent this from occurring.  Unexpectedly, the doughnut consumption 
had a relatively modest effect on most blood markers of cardiometabolic risk, with the 
major exception being the significant gain in body fat.  On the other hand, exercise not 
only prevented deterioration in all risk markers studied, but rather resulted in significant 
improvements in several outcome measures, including insulin sensitivity, nitric oxide 
bioavailability, and serum triglycerides.  These results are consistent with previous 
findings that suggested that the health benefits of exercise and/or aerobic fitness are 
independent of diet quality (Heroux et al, 2010; Huffman et al, 2012; Kouki et al, 2012), 
and also demonstrate that some cardiometabolic risk markers can be improved with 
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regular, vigorous exercise even when accompanied by the addition to the habitual, ad 
libitum diet of a fat-sugar supplement in the form of doughnuts. 
Body Composition 
  Increases in body weight and body fat could be expected as a result of adding 
~11,600 kcal, mostly from fat and sugar, to an ad libitum diet.  After three weeks of 
adding the fat-sugar load to the diet, participants in the doughnut + exercise group 
experienced no weight gain, and no change in body fat.  It is important to note that the 
estimated energy value of the exercise sessions (~4,360 kcal) was only about 38% of the 
energy value of the 3 dozen doughnuts (~11,600 kcal).  Even if the estimated energy cost 
of the excess post-exercise consumption (EPOC) is included (~10% of the exercise 
energy expenditure, or ~436 kcal), the cumulative energy expenditure of the exercise 
training sessions corresponds to only about 41% of the energy value of the 3 dozen 
doughnuts.  This suggests that exercise may have an “energy balance” effect beyond that 
attributable to just the energy value of the exercise itself. It is possible that weight 
maintenance during a period of overfeeding is attributable in part to the effect of exercise 
on increased sensitivity to satiety hormones (discussed below). 
 Similar results have been shown in rat studies examining the effects on 
overfeeding, which found that though increased energy expenditure through exercise 
training was compensated for by a significantly higher caloric intake in the training 
groups, trained animals consuming a  high-fat diet  gained significantly less weight than 
their sedentary control counterparts (Gollisch et al, 2009).  In fact, a number of 
previously published reports support the effectiveness of exercise as a means to prevent 
weight gain during periods of overfeeding (Gomez-Merino, Drogou, Guezennec, 
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Chennaoui, 2007; Boutelle, Kirschenbaum, Baker, Mitchell, 1990; Baker & 
Kirschenbaum, 1998). 
The doughnut only group gained ~1.4 kg body fat.  Using the standard values for 
the energy equivalent of fat tissue (9540 kcal; King et al 2009), this corresponds to an 
increase in energy value of body fat of approximately 13,350 kcal.  This is fairly close to 
the energy value of the 3 dozen doughnuts, but also suggests that consuming the 
doughnuts may have increased energy consumption slightly during the 3-week 
intervention.  Consuming carbohydrates increases carbohydrate utilization and suppresses 
fat oxidations (Jecquier, 1993).  Thus the consumption of ~11,600 kcal of mostly sugar 
and fat over three weeks, while maintaining an otherwise ad libitum diet, could be 
expected to increase fat storage.  The ~1.4 kg fat gain experienced by the doughnut only 
group is consistent with this expectation. 
Dietary intake during this study similarly parallels that of the frequent 
“overconsumptioin” that may occur during a holiday season.  The time between 
Thanksgiving and New Year’s is notorious for an increased propensity to over consume, 
especially high sugar/fat foods.  For most adults, there is a slight increase in weight over 
time, with the average weight gain in young adults ranging from 0.2 to 0.8 kg per year.  
Of that weight gain, there was a significant increase (0.48±2.22 kg) during the holiday 
period but not during the pre or post-holiday periods (Yanovski, Sovik, Nguyen, O’Neil 
& Sebring, 2000).  That is to say, weight gain that occurs during periods of “overeating,” 
such as during the holiday season, apparently is not subsequently lost (Yanovski et al, 
2000).  This could explain in part the pattern of adult weight gain that occurs in the 
United States.  The results of the present study suggest that exercise may be an important 
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behavior that could minimize, or prevent, unintended weight gain during short (~several 
weeks) periods of overconsumption relative to energy expenditure. 
In the holiday weight gain study of Yanovski et al (2000) only reported changes 
in activity and hunger’ were significantly associated with increased percentage of weight 
gain.  Those who reported lower activity or greater levels of hunger gained the most 
weight over the holiday period.  Even minimal weight gain experienced by normal weight 
subjects has a compounding effect if not lost from year to year.  This trend has been 
shown in the National Health and Nutrition Examination Survey follow-up study that 
among adults 25 to 44 years old, body weight measured at 10-year intervals increased by 
an average of 3.4 percent in men and 5.2 percent in women (Williamson, Kahn, 
Remington, Anda, 1990; Williamson, 1993). 
In studies with similar outcomes, exercise training prevented the effects of a high-
fat diet on characteristics of adipose tissue, with a more pronounced impact on visceral 
than subcutaneous fat tolerance (Gollisch et al, 2009; Xu et al, 2011).  It has been shown 
that one channel through which exercise acts is by increasing the brown adipocyte-
specific gene (UCP1) expression as well as increasing mitochondrial density (Xu et al, 
2011).  This expression is a critical step in activating brown adipogenesis.  Because 
brown adipose tissue acts similarly to skeletal muscle in the way of energy metabolism, 
an increase in brown adipose tissue could potential increase fat oxidation for the purpose 
of fuel availability.  Although the role of exercise in  brown adipose tissue development 
and metabolism in humans remains speculative, considerable variation in brown adipose 
tissue quantity and distribution has been shown to exist in young men (van Marken 
Lichtenbelt et al, 2009). 
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Exercise may be capable of triggering phenotypic changes in both brown and 
white adipose tissue that would cause it to be more metabolically active.  The cellular 
pathway by which this change in brown adipose is theorize to occur is by the increase of 
the brown adipocyte-specific protein UCP1 expression.  This enhances the oxidative 
phosphorylation through increased mitochondrial number and dissipation of energy as 
heat, improving the energy balance, and ameliorating adiposity and its complications (Xu 
et al, 2011).  Exercise has also been shown to reduce inflammation in visceral adipose 
tissue and inflammatory cytokines such as TNF-α and MCP-1 in white adipose tissue 
despite consuming a high fat diet (Gomez-Merino et al, 2007; Bradley, Jeon, Liu & 
Maratos-Flier, 2008).  In the current study, inflammatory cytokines were not measured; 
however, high fat/sugar diet and/or exercise training did ameliorate weight gain and 
prevent increases in adipose tissue.  Though more research is needed to support the 
findings regarding the alteration of adipose tissue function through exercise, the potential 
health implications for improving the viability of brown adipose tissue is apparent 
because high levels of brown fat (activity) may provide protection from diet-induced 
obesity, diabetes, and insulin resistance (Hamann, Flier & Lowell, 1996). 
Endothelial Function 
  The brachial artery flow-mediated dilation (FMD) results were 
unexpected.  Exercise training has been reported to increase FMD, with an effect that is 
most apparent after 2 to 4 weeks of training (Tinken, 2008).  FMD, reflecting functional 
changes in the endothelium, may decrease after this initial adaptation as a result of 
structural remodeling of the artery.  In fact, FMD after 8 weeks was no different than 
baseline FMD in the study of Tinken et al (2008).  This structural remodeling is 
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manifested by an enlargement of the arterial diameter.  In the present study, the baseline 
arterial diameter increased significantly more after the 3-week intervention in the 
exercise trained group.  Because FMD is inversely related to arterial diameter, the lack of 
change (actually, a trend for slight decrease) in FMD in the exercise-trained group may 
reflect some level of arterial remodeling in the exercise group.   If so, the present results 
suggest that arterial remodeling may occur much more rapidly than previously thought. 
 The lack of change in FMD must also be interpreted from the perspective of the 
actual changes in arterial diameter during the procedure.  FMD is calculated as the 
percent difference between the baseline diameter (prior to cuff inflation) and the peak 
diameter during the 5-minute measurement period after cuff deflation.  The exercise 
group experienced a significant increase in baseline diameter (reflecting arterial 
remodeling), and also had a significant increase in peak diameter after cuff release 
(suggestive of augmented endothelial function).  The FMD (i.e., percent increase in 
diameter) did not change (actually decrease slightly, but not statistically significantly) 
because the baseline diameter increased by more than the peak diameter.  Thus the 
current results suggest that both structural and functional changes in the brachial artery 
may have occurred as a result of exercise training that opposed any potentially 
detrimental effects of the doughnut-supplemented diet. 
 The nitric oxide results support this possibility.  Nitric oxide availability increased 
significantly in the exercise group, and nitric oxide plays a critical role in endothelial 
function.  By contrast, nitric oxide availability decreased in the control group.  This 
suggests that despite consuming a high fat/sugar load in the form of doughnuts for three 
weeks, four days per week of mixed-intensity exercise training was sufficient to mitigate 
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all negative dietary effects while triggering a concomitant increase in nitric oxide 
availability.  Previous studies have shown similar findings (de Morales, Davel, 
Rossoni, Antunes & Zanesco, 2008; McCarthy, Farney, Canale, Dessoulavy, Bloomer, 
2013).  The results of the control group in the present study are consistent with studies 
indicating significant declines in nitric oxide availability in response to a moderately 
high-fat load (Huang et al, 2011; Tamura et al., 2009).  A significant decline in nitric 
oxide bioavailability may result from a decrease in nitric oxide production or the 
scavenging of nitric oxide by reactive oxygen species (ROS).  In one study the decrease 
in nitric oxide was coupled with an increase in protein nitration which could potentially 
have adverse effects on tissue function (Huang et al, 2011). 
The significant changes in nitric oxide availability without a subsequent 
significant change in FMD calls attention to additional contributing mechanisms involved 
in vascular reactivity.  Potential mechanisms include antioxidant concentration, essential 
fatty acids, and oxidative stress.  The present study revealed no significant group 
differences in total antioxidant capacity across time.  Antioxidant capacity has been 
reported to be increased within ~16 h of an acute exercise bout, with higher-intensity 
exercise being more effective than moderate-intensity exercise (Tyldum et al, 2009).  In 
the present study, post-training fasting blood samples were drawn approximately 48 
hours after the last exercise session.  An increase in total antioxidant capacity of the 
blood resulting from an acute exercise bout may be only transient, with normalization 
occurring within 48 hours.  If so, this could explain the current finding of no increase in 
total antioxidant capacity of the blood after training.  Because total antioxidant capacity 
has also been reported to correlate strongly with FMD (Tyldum et al, 2009), a transient 
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effect of exercise on total antioxidant capacity may help explain the lack of a significant 
change in FMD in the group that received exercise training. 
A lack of increase in antioxidant capacity in the exercise group could be related to 
the significant rise in Nitric Oxide.  Nitric oxide, one of two primary free radicals 
generated during exercise, is highly reactive and easily converted to ROS.  Unstable free 
radical species attack cellular components which cause damage to lipids, proteins, and 
DNA.  These changes can trigger a number of disease pathologies.  Contraction of 
skeletal muscle and increases in ROS generation has been shown to have dose response 
relationship, with greater production coming from higher intensities or long duration 
(Powers & Jackson, 2008).  Because these ROS lead to muscle fatigue, the myocytes 
maintain at defense system integrating both exogenous and endogenous antioxidant 
molecules to mitigate pro-oxidative effects.  This theory suggests that the increased nitric 
oxide production led to increased production of oxidants which led to increased 
utilization of available antioxidants. 
Another potential confounder of the results is habitual diet.  Although participants 
were asked to refrain from taking nutritional supplements including fish-oil during this 
study, dietary consumption of essential fatty acids was not measured.  Previous research 
has shown that 1g eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) was 
able to preserve endothelial function after a high-fat meal in a healthy population (Fahs et 
al, 2010).  Other studies have also shown higher doses of omega-3 fatty acids to preserve 
both endothelial-independent (Armah et al. 2008) and endothelial-dependent function 
(Vogel et al. 2000; West et al., 2005) after a high fat meal.  Although consumption of 
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individual dietary fatty acids was not measured in the current study, the habitual fat 
intake was similar between groups (~77 g/day; ~28% of total energy). 
Cardiovascular Risk Factors 
 Overfeeding, either by carbohydrate, fat or a combination of both has been shown 
to adversely affect cardiovascular risk factors.  In the present study, most blood variables 
did not change, and this may reflect the population studied—reasonably healthy young 
males with normal blood pressures and normal blood lipid and glycemic values.  It is also 
possible that the fat-sugar supplement used in the current study--doughnuts--may not 
have incurred a large enough increase in overall saturated fat intake from baseline to 
bring about significant changes in either serum lipids or endothelial function.  . 
The consumption of three dozen doughnuts increased saturated fat intake by over 
300g, or by 17g/day on the 6 days in which the donuts were consumed.  Increased 
saturated fat intake has been shown to increase ectopic liver fat (Sevasianova et al, 2012).  
The ratio of saturated fatty acids to essential fatty acids in serum, and very low-density 
lipoprotein triglycerides also increased significantly.  Similar to changes in fat and body 
weight, additional overfeeding studies have addressed the development of dyslipidemia 
which has been documented as a result of overconsumption of sugar, even when 
substituted calorie for calorie for fat (Parks & Hellerstein, 2000).  An important 
mechanism is de novo lipogenesis, the synthesis of the saturated fatty acid palmitate, 
from glucose, fructose, or both.  The upregulation of this process is key because 
triglyceride synthesis and secretion by the liver is increased by the generation of 
palmitate in conjunction with glycerol and malonyl coenzyme A (Hudgins, 2012).  Some 
studies have seen up to a fivefold increase in liver triacylglycerol. 
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The triglyceride response in the control group in the present study is consistent 
with these previous findings.  A fat-sugar supplement would be expected to suppress lipid 
utilization, which could result in both an increase in fat storage as well as an increase in 
triglyceride formation.  The increase in triglycerides and gain in body fat in the doughnut 
only group can be seen as a natural consequence of an ad libitum diet supplemented with 
excess fat and sugar.  The reduction in triglyceride concentration in the exercise group, 
despite the consumption of the ~11,600 kcal in the form of doughnuts, highlights the 
beneficial impact of exercise on regulation of body fat and reducing fasting triglycerides.   
The significant decrease in triglycerides in the exercise group may be a function 
of increased skeletal muscle lipoprotein lipase protein expression which increases the 
hydrolysis of circulating triglycerides (Freese, Levine, Chapman, Hausman, Cureton, 
2011; Seip, Angelopoulos & Semenkovich, 1997).  Increased lipoprotein lipase activity, 
which aids in triglyceride clearance, peaks 4 to 8 hours after exercise and returning to 
baseline values within 24 hour post exercise.  These findings are similar to those in 
previous studies; however, the short duration of this study may have been too acute in 
nature to detect significant changes seen by other studies (Freese et al, 2011; Perry, 
Heigenhauser, Bonen & Spriet, 2008).  It is possible that the particular demographic had 
a sufficient level of metabolic flexibility to accommodate the short period of overfeeding 
experienced in this study. 
Glucose and Insulin 
In the present study, the exercise training resulted in a significant improvement in 
fasting insulin and insulin sensitivity (HOMA) despite consumption of a fat sugar 
supplemented diet.  In contrast, the doughnut only group experienced an increase in both 
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measures.  The improvement in insulin sensitivity was seen despite any significant 
changes in blood glucose levels.  These findings are consistent with previous findings 
which have shown that insulin sensitivity can be improved independently from 
improvements in serum lipids (Bradley et al, 2008).  In addition to aiding in the control of 
blood glucose, insulin is adipogenic.  At the periphery, insulin is influential in increasing 
body fat mass and stimulating the production and secretion of leptin, a potent satiety 
hormone that acts centrally to reduce food intake and increase energy expenditure.  
Insulin has been identified as a regulator of leptin because the fluctuations in plasma 
insulin concentrations in response to feeding parallel those of plasma leptin 
concentrations.   
Recent research has explored the impact of exercise and the feeding of various 
high-fat or high-sugar diets on satiety hormones such leptin, adiponectin and ghrelin.  
Leptin is an adipose-derived protein hormone that plays a critical role in the regulation of 
energy balance.  The suppression by leptin has more of a chronic control over appetite, 
that if suppressed can potentially lead to increased susceptibility to overfeeding and, 
resultantly, weight gain (Kieffer & Habener, 2000).  Circulating leptin levels are directly 
proportional to the percentage of body fat and fluctuate with changes in caloric intake and 
the amount of energy stored in adipocytes to maintain energy homeostasis (Chan et al, 
2003).  Leptin acts on the receptors in the hypothalamus to suppress appetite by binding 
to other chemical feeding stimulants such as neuropeptide Y.   
Based on the insulin and leptin interaction, increased insulin concentrations in 
addition to increased adipose tissue should result in an increase in leptin and a subsequent 
decrease in appetite.  Subjects in this study reported increased appetite at the onset of the 
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doughnut consumption.  Similar to the adaptation of the body toward hyperinsulinemia, if 
a period of sustained high leptin levels occurs, a subsequent decrease in leptin sensitivity 
has been shown (Myers, Cowley & Münzberg, 2008).  This leptin resistance could 
potentially lead to a blunted response from leptin in response to a high caloric feeding. 
 Similar to leptin, adiponectin is a protein hormone secreted from adipose tissue.  
This hormone aids in the control of energy metabolism through its critical role in 
carbohydrate regulation and lipid catabolism.  More specifically, this hormone is 
responsible for decreasing gluconeogenesis, increasing glucose uptake, increasing β-
oxidation, and facilitating triglyceride clearance (Díez & Iglesias, 2003; Nedvídková, 
Smitka, Kopský & Hainer, 2005; Vasseur, Leprêtre, Lacquemant & Froguel, 2003).  In 
contrast to leptin, adiponectin levels are inversely correlated to body fat percentage with 
weight reduction significantly increasing circulating levels.   
One explanation for the body weight responses of the exercise and control groups 
may be related to the location of lost or acquired body fat respectively.  Previous research 
has indicated that only subcutaneous leptin mRNA was elevated in sedentary high-fat-fed 
rats, suggesting that subcutaneous adipose tissue may play a predominant role in diet-
induced increases in serum leptin (Gollisch et al, 2009).  The current study did not 
measure compartment changes in body composition by subcutaneous or visceral.  
Another feasible mechanism contributing to these research findings is an alteration in 
sensitivity within the central signaling pathways of insulin and leptin.  Research has 
supported the hypothesis that hypothalamic effects of leptin might be mediated by 
phyosphatidylinositol 3-kinase (PI3K) signaling (Niswender et al, 2001).  Like insulin, 
leptin activates PI3K in hypothalamic neurons and this activation is required to reduce 
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food intake (Zhao et al, 2002; Niswender et al, 2001).  These findings support the theory 
that any interruption in the activation of insulin or leptin signaling pathways could 
attenuate the ability of adiposity-related hormones to regulate energy homeostasis.  
Human obesity seems to be characterized by resistance to adiposity signals within the 
hypothalamus, such as insulin and leptin, as suggested by markedly increased serum 
insulin and leptin levels, reflecting an increase in body adipose mass (Bagdade, 1967; 
Considine et al, 1996).  Despite this increase in adiposity signals, food consumption 
remains normal or high, which is a comparable metabolic dysfunction observed in type 2 
diabetes. 
 Acutely, impairment of insulin sensitivity has been shown to occur after only 3 
days of inactivity and overfeeding preceding changes in body composition (Knudsen et 
al, 2012).  After 7 days the metabolic consequences had worsened with an elevated 
fasting insulin level, a marked decrease in insulin sensitivity, and a compensatory 
increased insulin response to an oral glucose load to maintain glycemic control, 
signifying a loss of metabolic flexibility.  In a rodent model, a high-fat diet increased 
average blood glucose levels in sedentary rats but not in exercise-trained rats on the same 
diet (Gollisch et al, 2009).   
The aforementioned development of insulin resistance may partially be explained 
by increased liver fat, possibly in association with maximal lipid storage capacity in 
visceral adipose tissue.  The increase in de novo lipogenesis was significantly correlated 
with that in liver fat content.  These results provide support for the measurement of liver 
and plasma triglycerides and de novo lipogenesis after a high sugar load in populations at 
greatest risk for fatty liver.  Consequently, there is increased rationale for making dietary 
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recommendations to restrict sugars while targeting those at greatest risk of the identified 
pathogenic mechanisms of action. 
Fructose has also been recognized as being independently lipogenic because it is 
metabolized primarily in the liver (Bray, 2007).  Studies have shown that diets with high 
fructose intake result in lower post-prandial circulation of insulin and leptin as well as 
elevated ghrelin (Teff et al, 2004).  This hormone cocktail has been suggested to 
contribute to increased weight gain and the development of non-alcoholic fatty liver 
disease (Ouyang et al, 2008).  More specifically data shows that a 2% increase in body 
weight and similar increases in subcutaneous and visceral adipose tissue were 
accompanied by a 27% increase in liver fat measured (Sevastianova et al., 2012).  Other 
potential ramifications of this metabolic imbalance include increased oxidative stress, 
inflammation, and insulin resistance (Stanhope et al, 2009).  The implication that an 
indefinite overconsumption of calories from dietary sugar can cause or exacerbate fatty 
liver provides further support to public health recommendations to limit discretionary 
calories from dietary sugar intake. 
Conclusions 
The results of this study support existing research demonstrating that exercise can 
significantly attenuate a number of negative metabolic and weight-related changes that 
are associated with overfeeding.  The most compelling result of this study is that 4 
exercise sessions per week, each requiring ~30 minutes, were sufficient prevent weight 
and body fat gain during a 3-week period of consuming ~11,600 kcal in the form of 
doughnuts, as a supplement to normal diet in young men.  This prevention of weight and 
fat gain occurred despite the fact that the cumulative caloric cost of the exercise sessions 
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was only ~41% of the energy value of the 3 dozen doughnuts consumed.  Furthermore, 
increases in insulin sensitivity and total nitric oxide availability were observed in the 
exercise group despite the addition of ~11,600 kcal, largely as fat and sugar, to the 
subjects’ habitual diets.  Although consuming 3 dozen doughnuts did not appear to have 
consistent adverse effects on a number of cardiometabolic risk markers in the control 
group that did not exercise, the significant gain in body fat, averaging 1.5 kg in just 3 
weeks, suggests that regular exercise, especially during periods of increased energy 
consumption (e.g., holidays) may be essential for weight control and prevention and/or 
minimization of adult weight gain.  Whether these results extend to women, and other 
populations that are at increased risk for obesity, diabetes and/or cardiovascular disease, 
remains to be established. 
Strengths and Weaknesses 
 The supervised nature of the exercise training, in which all subjects in the exercise 
group completed 100% of their planned supervised exercise sessions, is a strength.  The 
fact that the control group did not change VO2peak is evidence that they did not engage 
in any unmeasured activity that might have affected their fitness levels.  Also, the manner 
in which the doughnuts were disbursed is a strength, as this enhanced compliance.  Lack 
of control over habitual diet is a weakness, but pre-intervention diet records indicated that 
both groups were similar in total energy intake and macronutrient composition of the diet.  
The results of the study may be specific to young, healthy males, with relatively normal 
values for cardiometabolic risk markers studied.   Also, the exercise training sessions 
were vigorous in nature.  Whether less intense exercise sessions could produce the same 
result remains to be established.  Follow-up studies on women, and other at-risk 
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populations need to be performed.  Furthermore, the study had a relatively small sample 
size, although it a priori adequately powered for the primary outcome (FMD), and most 
previously published studies of this nature have similar sample sizes. 
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will be answered by study personnel.  All aspects of the study will be explained and 
written consent will be obtained.  Participants will fill out a physical activity readiness 
questionnaire (PAR-Q) to ensure that they are suitable candidates for enrollment.  If they 
answer “yes” to any of the questions, they will not be allowed to participate.  If they 
answer “no” to each question, they will be allowed to participate.  Those who decide to 
participate after signing this consent form we will undergo a flow-mediated dilation 
(FMD) procedure (see below) to make sure we can adequately obtain an ultrasound 
image of each participant’s brachial artery.  Participants will complete an automated self-
administered 24-hour diet recall (ASA24; free online service provided by the National 
Institutes of Health (National Cancer Institute)). 
 
Subsequent Visits: 
 
Participants who agree to take part in the study will report to the Healthy Lifestyles 
Research Center in ISTB3 on the ASU Polytechnic Campus for all visits.  Participants 
randomly assigned to the Control group will have 11 additional visits beyond the 
screening visit (visits 2 through 12) over a 3-week period.  Participants randomly 
assigned to the exercise group will have a total of 14 visits beyond the screening visit 
(visits 2 thorough 15) over a 3-week period. Visits are described in detail below. 
 
Visit 2 (Baseline testing; both Control Group and Exercise Training Group): The 
participants will report for baseline testing at the ISTB3 building following an overnight 
fast (nothing but water after 10 PM).  
 
Participants will first have resting blood pressure measured, followed by a measurement 
of brachial artery flow-mediated dilation (described later).  Following this measurement, 
participants will have a fasting blood draw.   
 
Participants will have body composition measurements taken (BOD POD; described 
later).  All participants will perform a VO2max test on a treadmill to determine maximal 
oxygen uptake (described later). 
 
Participants will be randomly assigned to either the exercise or control group. 
 
Visits 3 through11 (Control Group) 
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These visits will be for picking up the doughnuts that will be provided to each participant 
during the 3-week study.  Participants will pick up doughnuts at the ISTB3 laboratory on 
Monday, Wednesday and Friday of each week.  Details are described below. 
 
Visits 3 through14 (Exercise Training Group only):  
The participants in the exercise training group will report to the ISTB3 building for 
exercise training.  Participants will train four (4) days per week for three (3) consecutive 
weeks.  Training sessions are not required to occur on consecutive days.  All exercise 
training will be performed on a motor-driven treadmill or a cycle ergometer.  The aerobic 
exercise training protocol will consist 2 sessions/week of continuous exercise and 2 
sessions/week of interval exercise performed on either a cycle ergometer or treadmill.  
Intensity on the treadmill will be achieved by walking on an incline or running or cycling 
against weighted resistance on the cycle ergometer.  The exercise protocols are as 
follows:  
• 2 days per week of continuous exercise: 30 minutes at a heart rate associated with 
75% V02max determined from the baseline cycle test. 
• 2 days per week of high-intensity interval exercise: 
• Ten 1-minute intervals at 90-95% of maximum heart rate, separated by 1 minute 
of active recovery at 60% of maximum heart rate (Little et al, 2011). 
• Four 4-minute intervals at 90-95% of maximum heart rate, separated by 3 minutes 
of active recovery at 60% of maximum heart rate (Wisloff et al, 2009). 
Each exercise session will being with a 5 minute warm-up (50-60% of maximum heart 
rate), and finish with a 5-minute cool-down (50-60% of maximum heart rate). 
 
Final Visit (Visit 12 for Control Group; Visit 15 for Exercise Training Group): 
Approximately 48 hours following the last training session, the participant will report to 
the ISTB3 building.  The testing procedures at this visit will be identical to those at Visit 
2. 
 
The procedures for testing are described in detail below: 
 
• Food Frequency Questionnaire: 
The ASA24 allows study participants to report their intake for the previous day from 
midnight to midnight. The Respondent application guides the participant through the 
completion of a 24HR for the previous day from midnight to midnight using a dynamic user 
interface.  
 
• Brachial Artery Flow Mediated Dilation (BAFMD): 
This is a non-invasive assessment of the ability of the brachial (upper arm) artery to dilate 
in response to an increase in blood flow, and is assessed using ultrasound.  This 
procedure is performed while the subject is lying supine on a padded ultrasound table.  
All measurements are made on the non-dominant arm.  A blood pressure cuff is 
positioned on the subject’s forearm.  After recording baseline ultrasound measures on the 
upper arm, the blood pressure cuff is inflated to 240 mmHg for 5 minutes.  The cuff is 
then deflated rapidly and brachial artery blood flow and arterial diameter are measured 
continuously for 5 minutes using the ultrasound probe.  These procedures conform to the 
published guidelines of the International Brachial Artery Reactivity Task Force (Corretti 
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MC, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-
mediated vasodilation of the brachial artery. Journal of the American College of 
Cardiology, 2002; 39: 257-265).   
 
• Blood Draw: 
Subjects will be asked to report for each blood draw (visits 2 and 12 for Control group; 
visits 2 and 15 for Exercise Training group) in the morning following an overnight fast 
(i.e., nothing but water after 10 PM).  Intravenous blood will be draw via one of the 
common antecubital fossa veins (cephalic, median cubital, or basilic vein) for 
measurement of blood lipids, glucose, insulin, and antioxidant capacity. All blood draws 
will be performed by a certified phlebotomist.  Approximately 15ml (3tsp) of blood will 
be collected for each blood draw. 
 
• Resting blood pressure will be measured using an automated blood pressure 
machine while the participant is sitting quietly in a comfortable chair. 
 
• Anthropometrics: 
Subjects’ weight will be measured on a standard Beam scale. Height will be assessed on a 
stadiometer. Body composition will be measured using a Bod Pod (air displacement 
plethysmography).   
 
• VO2max test: 
Subjects will be equipped with a mask attached to a hose, and Polar heart rate monitor for 
the metabolic measurement device (Parvo Truemax 2400TM) to measure ventilation and 
respiratory gas exchange data and heart rate continuously. After collecting resting data 
for 2 minutes, subjects will pedal on a stationary cycle ergometer at a cadence of their 
choice at 50 watts for 5 minutes for the warm-up phase. After the warm-up phase, load 
will increase continuously by 30 watts/min every minute until the subject cannot 
continue. Verbal encouragement will be given to all subjects throughout the entire test.  
The highest oxygen uptake during the test will be taken as the peak VO2.   
 
• Doughnut consumption: 
Each participant will be asked to consume 2 doughnuts per day, 6 days per week, for 3 
weeks.  Doughnuts will be purchased by the study researchers at a local Dunkin Donuts 
on Monday, Wednesday and Friday morning of each week.  Participants will be required 
to come to the ISTB3 laboratory on Monday, Wednesday, and Friday of each week for 
doughnut pickup.  This can be part of the regular exercise training visits for those in the 
Exercise Training group.  On each occasion participants will be given 4 doughnuts to 
consume over the next two days.  This will optimize compliance while ensuring that the 
doughnuts are fresh.  Participants will be provided a menu of doughnut options so that 
each participant will be able to choose the types of doughnuts that he would like most to 
consume.  All doughnuts will contain between 260 and 500 calories, of which at least 
70% of total calories are fat and sugar. 
 
• Dietary requirements: 
Each participant will be encouraged to maintain his normal diet during the three weeks, 
other than consuming the 2 doughnuts per day provided by study researchers as a 
requirement for participating in the study. 
 
c) What is the participant selection? Adult Males (ages 18-30 years) 
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d) What is the statistical design? Randomized control-group pretest-posttest design  
 
 
e) Describe whether the study involves randomization to control/intervention groups. The 
study will have participants randomized into either the aerobic training or control group.   
 
f) How will study results be used? Study results will be submitted in manuscript form to a peer 
reviewed journal. 
 
 
DATA SAFETY MONITORING BOARD (DSMB) 
 
6a) Does the study have a Data Safety Monitoring Board?   
 Yes (prompt submission of DSMB reports is required)        No 
 
b) If no, what is the structure/plan to report serious adverse events to the ASU IRB?  
All Adverse events will be reported to the IRB that could possibly (even remotely) be related to 
the study intervention.   If the event is immediately life threatening, or potentially severely 
debilitating, then it will be reported to the IRB within 48 hours. 
 
STUDY DURATION 
 
7a) What is the expected duration of the study through data analysis? (Attach a timeline, 
if applicable) 1 year 
 
b) What is the expected date that recruitment will begin? (must be after the submission 
date) October 1, 2012 
 
STUDY SITES 
 
8a) Where will the study be conducted? (Check all that apply) 
 On campus (Please indicate building(s) and room number (s) when known) ISTB3, Rm. 183 
 
 Off campus (Please provide location and letter of permission, where applicable)       
 
b) Is this study being reviewed by another IRB?  Yes   No 
 
Status of other IRB review:  Approved     Pending      Not yet submitted     
Attached 
 
INTERNATIONAL RESEARCH 
 
9a) Does this study include an international site?    Yes (list country)             No  
 
9b) If this is an international study, please provide a statement including the 
following items: 
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• The investigator’s familiarity with the culture in which the study in taking 
place.       
• Cultural norms and how this study may affect an individual’s standing in 
his/her community.       
• The standard of care in the community, how it differs from the proposed 
research procedures, and a plan for the continuation of care once the research is 
complete.       
 
RESEARCH PARTICIPANT INFORMATION 
10a) What are the inclusion criteria? (Use an expended list and attach a secondary 
sheet with explanation, where applicable. If you attach a secondary sheet, 
reference on which page the information can be found.) 
 
Participants must be nonsmoking males between the ages of 18-30yrs and be physically 
able to participate in vigorous physical activity.  The must also be willing to consume 2 
doughnuts per day, 6 days per week, for three consecutive weeks.  They must answer 
“no” to all questions of the Physical Activity Readiness Questionnaire. 
 
b) What are the exclusion criteria? 
 
Exclusion criteria: 
• Does not meet age requirement 
• Smoker 
• Answers “yes” to one or more questions on the Physical Activity Readiness 
Questionnaire 
• Unwillingness to sign informed consent 
• Currently engaged in a regular exercise program 
• Unwillingness to consume 2 doughnuts per day, 6 days per week, for 3 
consecutive weeks 
• Currently consumes greater than 4 donuts per week 
 
c) Please explain recruitment procedures in detail. (A copy of the recruitment 
materials must be attached.)  
 
Participants will be recruited through fliers placed on ASU campus.  Electronic media 
will also be used by posting the research study flier on websites with volunteer 
opportunity postings. 
 
d) What is the expected duration of participation of each participant? (total and at 
each session) 4 weeks total.  The screening visit will take about 1 hour.  The baseline 
(visit 2) and post-testing (either visit 12 or 15) sessions will require about 1.5 hours each.  
The doughnut pickup visits will last about 5 minutes each.  The exercise training visits 
will last about 45 minutes each.  Total time required for Control participants is 
approximately 4 hours 45 minutes.  Total time required for Exercise Training participants 
is approximately 13 hours. 
  
e) What is the expected number of individuals to be screened for enrollment?  40 
people 
 
f) What is the maximum number of individuals to be enrolled? (This includes 
individuals who drop out) 24 
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g) What is the approximate number of:    24 Males                0 Females 
 
h) Indicate the age range of the participants that you plan to enroll in your study.      
18 to 30                                                   
 
i) What is the race of participants? All race/ethnicities 
 
j) Does the study target any of the following participants?  Yes (please check 
all that apply)   No                                                   
 Children (under 18)                               Pregnant women 
 Decisionally impaired                        Economically disadvantaged 
 Prisoners or detainees                         Persons at high risk of becoming 
detained or imprisoned 
 Fetuses                                                    Patients, if yes – what is the status 
of their health? Type II diabetes 
 Native Americans                                   Non-English speakers (Include 
copy of all materials in   
                                                 language of participants) 
k) If any of the above categories have been checked, please state how you will 
protect the rights and privacy of these individuals.  
 
l) Does the study involve participants who have low-literacy?  Yes  No (If yes, 
please describe how investigators will ensure the participants’ understanding of the 
research):        
 
m) Does the study involve participants who are students or faculty of ASU?  
Yes  No (If yes, please state the   
      investigator’s involvement in the participant’s education/employment): 
 
ASU faculty or students that meet the inclusion/exclusion criteria will be eligible to 
participate in the study.  However, they will not be specifically targeted for recruitment.  
If ASU students, staff or faculty volunteer to participate, there will not be any effect on 
their employment or grade if they choose to withdraw from the study at time.   
 
COMPENSATION 
 
11. Will any type of compensation be used? (e.g. money, gift, raffle, extra credit, etc) 
a) Yes (Please describe what the compensation is): cash or gift certificate        No 
(go to question 12) 
Subjects assigned to the Control Group will receive $50 for completing both pre- and 
post-testing visits. 
Subjects assigned to the Exercise Training group will receive $100 for completing all 
exercise training sessions and both pre- and post-testing visits. 
b) Explain why the compensation is reasonable in relation to the experiences of and 
burden on participants. 
 
Financial compensation is commensurate with time commitment.  The higher 
compensation for those in the exercise training group is justified due to greater time 
commitment.  All participants will receive 3 dozen doughnuts over the course of the 3-
week study. 
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c) Is compensation for participation in a study or completion of the study? (Note: 
participants must be free to quit at any time without penalty). 
 Participation                           Completion 
 
d) If some or all participants are economically disadvantaged, explain how the 
compensation is provided in such as a way that participants cannot refuse the request to 
participate? This study will not be collecting information on socioeconomic status; all monetary 
compensation will be equal for all that complete the study. 
 
RISKS AND BENEFITS 
Please reference the proposal, where applicable and answer the questions below. 
 
12a) What are potential risks to participants?  
 
There is some risk associated with exercise, such as muscular soreness, musculoskeletal 
injury, tenderness and bruising from blood draws, and unexpected cardiovascular 
reactions to exercise, including shortness of breath, lightheadedness, fainting, chest pain, 
or death.  Trained and certified personnel will oversee the exercises and watch for signs 
of distress and stop the exercises if necessary.  There is a possible chance of weight gain 
as a result of daily caloric intake.  Additionally, a fat-sugar supplemented diet may lead 
to impairment of arterial function and blood pressure. 
 
b) What steps will the investigators take to reduce risks?  
 
To prevent infection, standard procedures for collecting blood samples will be used as 
well as properly cleaning the area and using a tourniquet to enlarge the vein prior to the 
draw.  Aerobic exercise protocol intensity will be relative to the participant’s fitness level 
and physiological signs will be monitored to prevent or catch any abnormal responses to 
exercise.  If necessary, first aid will be administered and 911 will be called if the incident 
requires such measures.  All instruction based on American College of Sports Medicine 
guidelines.   
 
c) What are any potential benefits to participants? 
 
Free exercise testing, results of blood analyses, as well as brachial artery flow-mediated dilation 
(assessment of vascular health), free body fat testing. 
 
d) Please note how the results of the study will affect the health and welfare of the 
general public. 
 
The results of this study will be used to evaluate the potential for high-intensity aerobic exercise 
to mitigate the anticipated negative health effects of regularly consuming foods (e.g., doughnuts) 
with a high content of fat and sugar. 
 
e) What are the types of incentives, if any, will participants receive? 
 
Participants will be compensated for their participation 
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f) What are the costs, if any, to participants? (This should be mentioned in the consent 
form): No cost to participant 
 
 
CONFIDENTIALITY 
 
13a) Describe the steps you will take to ensure the confidentiality of the participants and 
data.   
 
All information obtained in this study is strictly confidential unless disclosure is required by law. 
Data will be secured in a locked file cabinet in the faculty office of Glenn Gaesser.  The results of 
this research study may be used in reports, presentations, and publications, but the name or 
identity of the subject will not be revealed.  
 
b) How will you safeguard data that includes identifying or potentially identifying 
information (e.g. coding)?  
 
In order to maintain confidentiality of records, we will use subject codes on all data 
collected, maintain a master list separate and secure from all data collected, and limit 
access to all confidential information to the study investigators.    
 
c) When will identifiers be separated or removed from the data? At enrollment 
 
d) Where on campus will you store the data and media and ensure its security (videotapes 
and/or audiotapes)?  
 
Data will be coded and kept in a locked file cabinet or password-protected computer. 
 
e) How long do you plan to retain the data? Indefinitely 
 
f) How will you dispose of the data? 
 
Hard copies of blood work and patient information will be shredded and disposed.  
Electronic copies of the data will be permanently deleted. 
 
g) Is a certificate of confidentiality required?  Yes     No 
 
HIPAA 
 
14a) Are any of the data coming from covered entities under Health Insurance 
Portability and Accountability Act (HIPAA)?  Yes     No      (If yes, please 
describe):       
 
b) Is a data use agreement required?  Yes     No 
 
c) Is a HIPAA Waiver of Authorization being requested?  Yes     No 
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DATA SOURCES AND USES 
 
15a) Please check all the ways that you will obtain data: (Copies of written and 
oral questions must be provided for ASU IRB review and approval prior to 
implementation.) 
 Interviews                                      Questionnaires/Surveys 
 Focus Groups                               Public Records 
 Medical Records                            Biological Specimens  
 Registries                                       Other  Experimental data collection in 
the laboratory 
 
b) How will the data be used? (Check all that apply) 
 Dissertation                                                      Publication/journal article  
 Thesis                                                          Undergraduate honors project 
 Results released to participants/parents         Results released to employer or 
school  
 Results released to agency or organization    Conferences/presentations                
 Other (please describe):        
 
INFORMED CONSENT 
 
16. Describe the procedures you will use to obtain and document informed consent 
and assent.  Attach copies of the forms that you will use. In the case of secondary data, 
please attach original informed consent or describe below why it has not been included. 
Fully justify any request for a waiver of written consent or parental consent for minors. 
(The ASU IRB website has additional information and sample consent and assent forms.)   
 
All individuals who inquire about participation in the study will be provided with a brief 
verbal overview of the study details, and will be apprised of the inclusion and exclusion 
criteria.  Individuals expressing an interest to enroll will be provided with a copy of the 
consent form to read at their convenience.  Those individuals wishing to continue with 
the enrollment will meet with one of the study investigators in order to complete the 
written consent process.  A copy of the consent form is attached. 
 
INVESTIGATIONAL NEW DRUG OR DEVICE 
 
17a) Does this study involve an investigational new drug (within the meaning of 21 
U.S.C. 355(i) or 357(d)) or a significant risk device (as defined in 21 CFR 812.3(m)? 
  Yes      No (If no, go to question 18. If unsure, go to: 
www.fda.gov/oc/ohrt/irbs/). 
 
b) What is the drug or device?       
 
c) Has the 30-day interval required for investigational new drugs and for significant risk 
devices elapsed, or has the FDA has waived that requirement?       
 
d) If the 30-day interval has expired, has the FDA requested that the drug or 
device be withheld or restricted for use in human subjects?  Yes     No 
97 
 
DRUGS 
 
18. What are the drugs to be used and in what dosage? (If no drugs will be used, 
please write N/A.)  N/A 
 
RADIATION 
 
19a) Will ionizing radiation (x-rays and or radiopharmaceuticals) be used?   
Yes     No (If yes, include a copy of the radiation certification). 
 
b) Will non-ionizing radiation (MRI, ultrasound, lasers, ultraviolet) be used?     
Yes   Ultrasound   No 
 
The ultrasound procedure will be performed by co-investigator Brandon Sawyer.  He has 
performed more than 100 ultrasound procedures, which is the number recommended by 
the International Brachial Artery Reactivity Task Force (Corretti MC, et al. Guidelines 
for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the 
brachial artery. Journal of the American College of Cardiology, 2002; 39: 257-265). 
 
BIOLOGICAL MATERIALS 
 
20a) Will biological materials be collected from subjects or given to subjects?  
Yes      No (If no, please skip to question 21) 
 
b) Provide a description of the material (blood, tissue, vectors, antibodies, etc.) 
that will be used:  
 
Fasting Lipid Panel, Blood glucose 
 
c) If the study involves human blood, do you have the required ASU Biosafety 
disclosure on file?  Yes   No 
(If yes, what is the biosafety disclosure number?)  09-204 
(If yes, when and how are the samples to be destroyed?  Note: an active protocol 
is required the entire period that the samples are retained)   
 
The samples will be destroyed 6 months after the data analysis by putting the vials in a 
sealed plastic-lined biohazard waste box appropriate for blood and glass.  The biohazard 
box will be labeled with contents, date, and originating location information.  
 
d) Will any of the material being used in the study come from a third party?   
Yes     No (If yes, attach copy of the Material Transfer Agreement if required.)   
 
e) Does this study involve transfer of genetic material of animal tissue into 
humans?  Yes     No 
(If yes, please cite the ASU Institutional Biosafety Disclosure number).       
 
GENETIC ANALYSIS 
 
21a)  Does this study involve genetic analysis?  Yes     No (If no, please skip 
to question 22). 
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b)  What sources of genetic material will be studied (blood, tissue, DNA)?       
 
c) Please specify whether the genetic analysis involves pedigree, positional 
cloning, mutational polymorphism, or gene therapy research.       
 
d) Please specify whether: 
 Stored samples already exist                           
 Samples will be collected specifically for this study          
 Stored samples already exist from a previously approved study      
 Samples collected are part of a routine clinical procedure 
 Samples are discarded, already existing, and de-identified  
 
e) If stored samples will be used, did participants consent to the use of their stored 
sample(s)? 
  Yes     No (If yes, was the consent prospective to collection of the sample, 
or retrospective of the collection of the sample?)       
 
f) Will any identifiers be maintained?  Yes     No   (If yes, please specify) 
      
 
g) When will samples be destroyed or discarded?       
 
h) Are any of the diseases being studied considered preventable? Yes     No 
 
i) Is there a possibility of an incidental finding of a genetic condition?  Yes    
 No  
If so, is there a plan to disclose this to the individual?       
 
j) Will this information be kept confidential from third parties such as employers, 
or insurance companies, or will findings be included in the participant’s medical 
record for clinical treatment?       
 
k) How will other risks (e.g. discovery of information regarding paternity or 
ancestry) be disclosed to subject?       
CONFLICT OF INTEREST AND COMMERCIALIZATION 
 
22a) Does any member of the research team have a potential conflict of interest with this 
study that could affect study participants and/or study outcome? For more information 
about examples of conflicts of interests, please visit the ASU objectivity website: 
http://researchintegrity.asu.edu/coi  
 Yes    No  (If yes, please describe and disclose in the consent form)     
 
b) Does the PI or Co-I have a current conflict disclosure questionnaire on file at the ASU 
Office of Research Integrity and  
Assurance? 
 Yes    No  (Review ASU’s objectivity in research policy: http://www.asu.edu/aad/manuals/rsp/rsp206.html) 
 
c) Among the research team, is there any financial association that could affect any of the 
following: the study outcome, data analysis, enrollment of subjects, study design? 
 Yes    No (If yes, please describe and disclose in the consent form)     
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d) Are there any plans for commercial development related to the findings of this study?  
 Yes    (If yes, please describe.)                  No 
  
e) Will the investigator or member of the investigator’s family financially benefit if the 
findings are commercialized? 
 Yes    (If yes, please describe.)                  No   
 
f) Will participants financially benefit if the findings are commercialized?  
 Yes    (If yes, please describe.)                  No   
 
g) If there are conflicts of interests, please describe the ways in which the 
researchers will minimize harm to research subjects and/or the objectivity of 
research. N/A 
 
TRAINING 
 
23. The research team must document completion of human subjects training.  
 
Please provide the date that the PI and Co-Investigators completed the training.   
 
Glenn Gaesser  7-23-2012  
Laurie Black   9-26-2012 
Brandon Sawyer 6-13-2011 
Dharini Bhammar 9-09-2011 
Wesley Tucker  9-01-2010 
 
(Attach a copy of the NIH Certificate for Human Participants Protections Education for 
Research Teams or CITI Training: http://researchintegrity.asu.edu/training/humans for 
the PI and Co-Investigators. Training must be within the past 3 years)   
 
REQUIRED SIGNATURES 
 
24. By signing this application form: 
•  I agree to accept responsibility for the rights and welfare of the human subjects 
involved with this study. 
•  I believe that the benefits outweigh the risks to the participants in this study.  
•  I agree to comply with Arizona State University IRB policies and procedures.   
•  I certify that, to the best of my knowledge, I am in compliance with the Department of 
Health and Human Services policies and procedures regarding the protection of human 
subjects.  
 
Glenn Gaesser                                                                                               9/26/2012 
Principal Investigator                                                                Date              
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Attach a copy of the PI’s CV unless one is already on file with the Research Compliance 
Office. 
 
                                              9/26/2012                    Linda Vaughan 
Department Chair/Dean                  Date      Print Department 
Chair/Dean Name 
(If the PI is the Department Chair or Dean, the application must be signed by another 
authorized Department/ School/College level Administrator) 
 
FOR OFFICE USE: This application has been reviewed by the Arizona State 
University IRB: 
 Full Board Review      
 Expedite   Categories:__________ 
 Exempt    Categories: __________ 
 
             Approved     Deferred      Disapproved 
             
Project requires review more often than annual   
Every       months 
 
 
Signature of IRB Chair/ IRB Member:                                                    Date:       
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APPENDIX B 
IRB MODIFICATION 1 
  
Arizona State University 
Office of Research Integrity 
and Assurance 
660 S. Mill Avenue Suite 315 
Tempe AZ 85287-6111 
Mail Code 6111 
Phone:  480-965-6788 
Fax: (480) 965-7772 
                      
                     
 Modification Form
INVESTIGATOR INFORMATION
PROTOCOL TITLE:  Effects of a fat
supplemented diet, with and without exercise 
training, on endothelial function, blood 
pressure, and blood markers of 
cardiovascular risk 
PRINCIPAL INVESTIGATOR:
Gaesser 
CAMPUS ADDRESS: 500 North 3
Phoenix, AZ 85004 
CO-INVESTIGATORS: 
FUNDING STATUS:  
If project is funded or funding is being sought, provide list of all 
sponsors and grant numbers: 
TYPE OF MODIFICATION
Please attach any revised documents (forms, scripts, etc). Attach 
a brief summary of the proposed changes as well as a justification. 
 New Procedures
 Study Title Change
 Change in Study 
Personnel 
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 For Office Use Only:
Date Received:      
 
 
 
 Institutional Review Board 
(IRB) 
 
-sugar HS # 1209008325
 Glenn DEPARTMENT/ 
CENTER: Exercise and 
Wellness/Healthy Lifestyles 
Research Center 
rd
 Street, PHONE: 480-727-1884
EMAIL:  
glenn.gaesser@asu.edu
Laurie Black, Brandon Sawyer, 
      
 (CHECK ALL THAT APPLY)
 Attach a description of the new 
procedures and a revised consent form. 
-VO2max test will be conducted on a 
cycle ergometer rather than a treadmill.
-Training sessions will occur on
treadmill or a cycle ergometer (intensity 
remains the same as previously stated)
 What is the new title?       
 Add  (include the name, role, and 
contact information. Include copies of 
training certificates: 
http://researchintegrity.asu.edu/train
ing/humans 
 Delete  
 
         
 
 
 
 
 
 
 
 a 
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 Change of Site  Add (include the name and 
location. If this changes the 
enrollment, that should be noted 
below.)       
 Modify 
 Delete 
 Change in 
Enrollment 
Attach a narrative justifying the 
change. If this will affect the consent, 
send a revised consent form as well. 
Participants will not be allowed to 
participate in this study if they 
currently consume greater than 4 
doughnuts per week. 
 Consent Change Attach a copy and describe the 
change(s).       
 Advertisement Attach copies of the advertisement or 
announcement.       
 Instruments 
(surveys, 
questionnaires, 
interviews, etc) 
Attach copies of the proposed 
instruments and describe any changes 
from the approved protocol.  If you are 
adding or deleting any instruments or 
items to an instrument, describe what 
the changes are and submit the revised 
materials.       
 Other Describe the changes. If this affects the 
consent process, submit a revised 
consent form.       
SIGNATURE 
PRINCIPAL 
INVESTIGATOR: 
      
Name (first, middle, last):       
 
Signature:                                               Date: 
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APPENDIX C 
IRB MODIFICATION 2 
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INVESTIGATOR INFORMATION 
PROTOCOL TITLE:  Effects of a fat-sugar 
supplemented diet, with and without exercise 
training, on endothelial function, blood 
pressure, and blood markers of cardiovascular 
risk 
HS #       
PRINCIPAL INVESTIGATOR: Glenn 
Gaesser 
DEPARTMENT/ 
CENTER: Exercise and 
Wellness/Healthy Lifestyles 
Research Center 
CAMPUS ADDRESS: 500 North 3rd Street, 
Phoenix, AZ 85004 
PHONE: 480-727-1884 
EMAIL:  
glenn.gaesser@asu.edu 
CO-INVESTIGATORS: Laurie Black, Brandon Sawyer, Wesley 
Tucker, Dharini Bhammer 
FUNDING STATUS:  
If project is funded or funding is being sought, provide list of all 
sponsors and grant numbers:       
TYPE OF MODIFICATION (CHECK ALL THAT APPLY) 
Please attach any revised documents (forms, scripts, etc). Attach a 
brief summary of the proposed changes as well as a justification.  
 New Procedures Attach a description of the new 
procedures and a revised consent form.  
-Subjects will complete a Food Recall at 
the beginning and end of the study. 
 
 Study Title Change What is the new title?       
 
 Change in Study 
Personnel 
 Add  (include the name, role, and 
contact information. Include copies of 
training certificates: 
http://researchintegrity.asu.edu/traini
ng/humans  
      
 Delete  
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 Change of Site  Add (include the name and location. 
If this changes the enrollment, that 
should be noted below.)       
 Modify 
 Delete 
 Change in 
Enrollment 
Attach a narrative justifying the 
change. If this will affect the consent, 
send a revised consent form as well. 
 Consent Change Attach a copy and describe the 
change(s).       
 
 Advertisement Attach copies of the advertisement or 
announcement.       
 
 Instruments 
(surveys, 
questionnaires, 
interviews, etc) 
Attach copies of the proposed 
instruments and describe any changes 
from the approved protocol.  If you are 
adding or deleting any instruments or 
items to an instrument, describe what 
the changes are and submit the revised 
materials.  
Online version of ASA24 for research 
purposes 
 Other Describe the changes. If this affects the 
consent process, submit a revised 
consent form.       
SIGNATURE 
PRINCIPAL 
INVESTIGATOR: 
      
Name (first, middle, last):       
 
Signature:                                               Date: 
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Healthy men (18 – 30 years old) are needed for a 
study looking at the health effects of consuming 
2 doughnuts daily, 6 days per week for 3 weeks, 
with or without exercise training 
 
Compensation 
$50 - $100 plus 3 dozen doughnuts 
 
This study takes place at the Healthy Lifestyles Research Center at the ASU 
Polytechnic Campus in East Mesa, and requires approximately 5 hours 
(control group) or 13 hours (exercise training group) of total time 
commitment over 3 weeks. Your participation throughout the study is 
completely voluntary. 
 
Eligible participants must be generally sedentary, nonsmokers. Must be in 
generally good health, have no restrictions for participating in vigorous 
intensity physical activity, and must not be taking any medications for blood 
pressure, cholesterol, diabetes or a heart condition.  
 
Please contact: 
Laurie Black (614-359-0207; laurie.e.black@asu.edu) 
 
Do You Like Doughnuts?
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Informed Consent 
 
Effects of a fat-sugar supplemented diet, with and without exercise training, on 
endothelial function and blood markers of cardiovascular risk. 
 
INTRODUCTION 
The purposes of this form are to provide you (as a prospective research study participant) 
information that may affect your decision as to whether or not to participate in this 
research and to record the consent of those who agree to be involved in the study. 
 
RESEARCHERS 
Glenn Gaesser, PhD, a professor, and Laurie Black, Brandon Sawyer, Dharini Bhammar 
and Wesley Tucker, doctoral students, in the Physical Activity, Nutrition and Wellness 
Program in the School of Nutrition and Health Promotion have requested your 
participation in a research study. 
 
STUDY PURPOSE 
Our primary objective is to determine whether exercise training can prevent the 
anticipated deleterious effects of a fat-sugar supplemented diet (in the form of two 
doughnuts per day, 6 days per week, for 3 weeks) on peripheral artery function, blood 
pressure, and blood markers of cardiovascular risk in healthy young men. 
 
DESCRIPTION OF RESEARCH STUDY 
If you decide to participate, then as a study participant you will join a study involving 
research on the effects of vigorous exercise training on blood lipids, blood glucose, and 
cardiovascular disease risk factors. 
 
You are being asked to participate in this study because you are a relatively sedentary 
male and are, 18 - 30 years of age, in good health, and capable of performing vigorous 
physical activity.  You must also be willing to consume two doughnuts per day, six days 
per week, for three weeks. 
 
As a study participant you will have between 11 and 14 total visits to the Health 
Lifestyles Laboratory in ISTB3 room 181 on the Polytechnic campus of ASU.  The 
number of visits depends on whether you are (randomly) assigned to the Control Group 
(11 visits) or Exercise Training Group (14 visits). 
 
Visit 1 (screening): 
Your first visit will involve coming to the test site on the ASU Polytechnic campus and 
filling out a physical activity readiness questionnaire that consists of 7 questions designed 
to assess whether participation in this study is appropriate for you.  All aspects of the 
study will be explained to you, and we will answer any questions you may have. If you 
decide to participate after signing this consent form we will conduct the flow-mediated 
dilation (FMD) procedure (see below) to make sure we can adequately image your 
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brachial artery. During this visit you will also complete an automated self-administered 
24-hour diet recall.  This visit will take approximately 90 minutes.   
 
Testing: 
All testing will be completed at baseline and after 3-weeks for both the exercise training 
and control groups. 
 
Baseline and 3-Week Testing (Visits 2 and 12 (Control Group); Visits 2 and 15 
(Exercise Training Group): 
 
• You will need to arrive at the laboratory in a fasted state (nothing but water after 
10 PM) 
 
• Height and weight will be measured using a standard scale. 
 
 BOD POD: 
Your body composition (relative amounts of fat and lean tissue) will be 
determined by using a BOD POD, which is an air-displacement plethysmography 
procedure.  This requires that you sit down in a fiberglass shell chamber (that 
looks something like a giant egg shell), and rest quietly for a few moments.  You 
will wear a special bathing suit during this procedure.  A clean bathing suit will be 
provided by researchers at ASU.   
 
• Resting blood pressure will be measured using an automated blood pressure 
machine. 
 
 Brachial Artery Flow-Mediated Dilation:  
This procedure involves taking ultrasound images of an artery in your upper arm 
before, during, and after a blood pressure cuff is inflated around your forearm.  
All measurements are made on your non-dominant arm.  After lying quietly on a 
padded ultrasound table for 20 minutes, a blood pressure cuff will be positioned 
on your forearm.  After recording baseline ultrasound measures on your upper 
arm, the blood pressure cuff will be inflated to a pressure of 240 mmHg (enough 
to stop blood flow to your wrist and hand), and kept in place for 5 minutes.  You 
may experience a tingling feeling in your hand, which is normal.  The blood 
pressure cuff will then be deflated rapidly and ultrasound measures will be taken 
for 5 minutes. 
 
• A small amount of blood (approximately 3 teaspoons) will be drawn from one of 
the veins in your forearm for measurement of blood lipids, glucose, insulin, 
insulin sensitivity, and antioxidant capacity. 
 
• Maximal Exercise Test: You will undergo a maximal exercise test on a bicycle.  
The test begins with you pedaling at a comfortable pace with little resistance for 5 
minutes, after which the resistance will gradually increase until you reach a point 
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that you no longer can or want to continue.  You will be asked to give an effort 
that is as close to maximal as you feel you are capable of.  During this test you 
will wear a lightweight device that allows us to measure your breathing. This 
device consists of a shoulder/chest harness, which holds the gas analyzers in small 
pouches secured to the harness, and a facemask assembly that allows us to 
measure your breathing.  The facemask is made of a flexible, rubbery-type 
material that fits over your mouth and nose and allows you to breathe naturally.  
The facemask is held in place with an elasticized net that fits over the back of 
your head and attaches to the facemask via elastic straps.  You will also wear a 
Polar heart rate monitor, which is a lightweight, elasticized strap that you wear 
around your chest.  This test takes about 20 minutes. 
  
Total time for testing visit 1 is approximately 90 minutes 
 
Exercise Training (Visits 3 through 14 for Exercise Training Group) 
If you are randomized into the exercise group you will be asked to complete 4 exercise 
sessions per week for 3 weeks for a total of 12 exercise sessions.  These training sessions 
will include 2 high-intensity interval exercise training session and 2 continuous steady-
state exercise training sessions per week.  All exercise will be conducted on a treadmill.   
Training days and times will be flexible, according to your schedule. 
 
• Continuous Exercise Training (2 times per week): 
o 30 minutes at a heart rate corresponding to 75% of your maximum aerobic 
capacity determined from the baseline treadmill test. .  You will have a 5-
minute warm-up and 5-minute cool-down at 50-60% of your maximum 
heart rate. 
o  
• High-intensity Interval Exercise Training (2 times per week): 
o Once per week you will perform the following routine:  
• 5-minute warm up at 50-60% of your maximum heart rate 
• Ten 1-minute intervals at 90-95% your maximum heart rate separated 
by 1 minute of exercise at a low intensity 
• 5 minute cool down at 50-60% of your maximum heart rate 
o Once per week you will perform the following routine: 
• 5-minute warm up at 50-60% of your maximum heart rate 
• Four 4-minute intervals at 90-95% of your maximum heart rate 
separated by 3 minutes of exercise at a low intensity (about 60% of 
maximum heart rate) 
• 5 minute cool down at 50-60% of your maximum heart rate 
 
Total time for each exercise training visit is approximately 45 minutes, including warm-
up and cool-down. 
 
Doughnut Pickup (Visits 2 through 11 for Control Group; Visits 3, 4, 6, 7, 8, 10, 11, 
12 and 13 for Exercise Training Group) 
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You will be asked to consume 2 doughnuts per day, 6 days per week, for 3 weeks.  
Doughnuts will be purchased by the study researchers at a local Dunkin Donuts on 
Monday, Wednesday and Friday morning of each week.  You will be required to come to 
the ISTB3 laboratory on Monday, Wednesday, and Friday of each week for doughnut 
pickup.  This visit can be part of your regular exercise training visit if you are in the 
Exercise Training group.  On each occasion you will be given 4 doughnuts to consume 
over the next two days. You will be provided a menu of doughnut options so that you will 
be able to choose the types of doughnuts that you would like most to consume.  You may 
consume the doughnuts at any time of the day that you choose.  We ask that you not 
consume all 4 doughnuts in one day. 
 
Total time commitment for completion of the study is approximately 5 hours and 15 
minutes if you are in the Control Group and approximately 13.5 hours if you are in the 
Exercise Training Group. 
 
RISKS 
 
Research studies often involve some risks.  The risks of exercise include local muscle 
soreness, abnormal changes in blood pressure, nausea, faintness, dizziness, irregular 
heartbeats (rare), and, in very rare instances, heart attack.  
 
You will be monitored by trained investigators and if there are any adverse effects, the 
exercise testing or the exercise session will be halted. All exercise testing procedures will 
comply with the guidelines for exercise test administration as recommended by the 
American College of Sports Medicine and required by the Healthy Lifestyles Research 
Center at Arizona State University. You will be asked not to attempt any exercise that 
you feel is beyond your physical abilities.  If you experience discomfort, feel you are 
unable to continue or wish to stop an exercise at any point, you are requested to inform 
the investigator immediately.  
 
The blood draw involves a needle puncture in your forearm and hence may lead to some 
discomfort as well as a slight risk of infection. These will be minimized by using standard 
procedures for controlling blood-borne pathogens as well as properly cleaning the needle 
insertion site.  Other possible risks of a blood draw include dizziness, fainting, nausea, 
and vomiting. All blood draws will be conducted while you are seated to ensure your 
safety in case any of these possible side effects occur.  
 
There is a possible chance of weight gain as a result of potentially higher daily 
caloric intake.  Additionally, a fat-sugar supplemented diet may lead to 
impairment of arterial function and blood pressure. 
 
As with any research, there is some possibility that you may be subject to risks that have 
not yet been identified.   
 
BENEFITS  
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Although there may be no direct benefits to you, you will be provided information on 
your test results and the study results if you would like us to contact you when the study 
is complete. 
 
NEW INFORMATION 
If the researchers find new information during the study that would reasonably change 
your decision about participating, then they will provide this information to you. 
 
CONFIDENTIALITY 
All information obtained in this study is strictly confidential unless disclosure is required 
by law.  The results of this research study may be used in reports, presentations, and 
publications, but your name or identity will not be revealed. In order to maintain 
confidentiality of your records, Dr. Gaesser will use subject codes on all data collected, 
maintain a master list separate and secure from all data collected, and limit access to all 
confidential information to the study investigators.    
 
WITHDRAWAL PRIVILEGE 
It is ok for you to say no. Even if you say yes now, you are free to say no later, and 
withdraw from the study at any time.  Your decision will not affect your relationship with 
Arizona State University or otherwise cause a loss of benefits to which you might 
otherwise be entitled.  Your participation is voluntary and if you decide not to participate 
or decide to withdraw from the study it will not affect your grade, treatment, care, 
employment status. 
 
COSTS AND PAYMENTS 
All study procedures will be provided to you at no cost to you. If you are in the Control 
Group you will be paid $50 (cash) for completion the study, including both testing visits 
and successful pickup of doughnuts on three days each week.  If you are in the Exercise 
Training Group you will be paid $100 (cash) for completion of the study, including both 
testing visits and all exercise training sessions.. You will also receive 3 dozen free donuts 
to consume during the 3 weeks of testing. Partial payment will be made in the following 
manner if you only complete some of the visits.  
• Control Group:  Completion of Baseline Testing but failure to complete final visit 
testing:$25 
• Exercise Training Group: Completion of Baseline testing and some/all of the 
exercise training session, but failure to complete final visit testing:  $50  
 
COMPENSATION FOR ILLNESS AND INJURY 
If you agree to participate in the study, then your consent does not waive any of your 
legal rights. However, no funds have been set aside to compensate you in the event of 
injury. In the event of a medical emergency first aid will be administered and if 
necessary, 911 will be called. 
 
VOLUNTARY CONSENT 
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Any questions you have concerning the research study or your participation in the study, 
before or after your consent, will be answered by Dr. Glenn Gaesser, 500 N 3rd ST, 
Phoenix, AZ 85004; 602-827-2283; 480-727-1884. 
 
If you have questions about your rights as a subject/participant in this research, or if you 
feel you have been placed at risk, you can contact the Chair of the Human Subjects 
Institutional Review Board, through the ASU Office of Research Integrity and 
Assurance, at 480-965 6788.   
 
This form explains the nature, demands, benefits and any risk of the project.  By signing 
this form you agree knowingly to assume any risks involved.  Remember, your 
participation is voluntary.  You may choose not to participate or to withdraw your 
consent and discontinue participation at any time without penalty or loss of benefit.  In 
signing this consent form, you are not waiving any legal claims, rights, or remedies.  A 
copy of this consent form will be given to you.   
 
Your signature below indicates that you consent to participate in the above study 
 
_________________________ _________________________  __________ 
Subject's Signature   Printed Name           Date 
_________________________   __________________________       
Contact phone number                 E-mail 
 
INVESTIGATOR’S STATEMENT 
"I certify that I have explained to the above individual the nature and purpose, the 
potential benefits and possible risks associated with participation in this research study, 
have answered any questions that have been raised, and have witnessed the above 
signature. These elements of Informed Consent conform to the Assurance given by 
Arizona State University to the Office for Human Research Protections to protect the 
rights of human subjects. I have provided the subject/participant a copy of this signed 
consent document." 
 
Signature of Investigator___________________________    Date___________ 
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Participant # 
Please Select 4 Doughnuts from each Category:   
      Category 1 
 
 
QTY 
  
QTY 
 Apple n Spice   
 
Jelly Filled   
 Bavarian Kreme   
 
Lemon Filled   
 Fall Harvest   
 
Maple Frosted   
 French Cruller   
 
Strawberry Frosted   
 Glazed   
  
  
 
      Category 2 
 
 
QTY 
  
QTY 
 Blueberry Cake   
 
Old Fashioned Cake   
 Boston Kreme   
 
Coconut   
 Boston Scream   
 
Powdered Cake   
 Cinnamon Cake   
 
Vanilla Cocoa Kreme   
 
      Category 3 
 
 
QTY 
  
QTY 
 Chocolate Frosted Cake   
 
Glazed Cake   
 Chocolate Glazed Cake   
 
Glazed Chocolate Cake   
 Chocolate Kreme Filled   
 
Pumpkin   
 Chocolate Long John   
 
Red Velvet Cake   
 Double Chocolate Cake   
 
Vanilla Kreme Filled   
 Éclair   
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STATISTICAL ANALYSIS OUTPUT 
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Tests of Normality 
Group 
Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
Age 1 
.212 6 .200 .933 6 .607 
2 
.209 7 .200 .878 7 .218 
Height 1 
.218 6 .200 .919 6 .496 
2 
.328 7 .022 .736 7 .009 
WeightPre 1 
.194 6 .200 .888 6 .305 
2 
.179 7 .200 .943 7 .661 
WeightPost 1 
.210 6 .200 .873 6 .237 
2 
.174 7 .200 .949 7 .721 
WeightDelt 1 
.180 6 .200 .921 6 .514 
2 
.263 7 .152 .908 7 .383 
BodyFatPre 1 
.230 6 .200 .927 6 .556 
2 
.236 7 .200 .884 7 .246 
BodyFatPost 1 
.258 6 .200 .884 6 .286 
2 
.201 7 .200 .924 7 .497 
BodyFatDelta 1 
.198 6 .200 .898 6 .364 
2 
.234 7 .200 .866 7 .171 
FatMassPre 1 
.244 6 .200 .933 6 .600 
2 
.279 7 .105 .811 7 .053 
FatMassPost 1 
.254 6 .200 .896 6 .348 
2 
.246 7 .200 .859 7 .148 
FatMassDelta 1 
.172 6 .200 .949 6 .730 
2 
.140 7 .200 .973 7 .922 
SystolicPre 1 
.299 6 .102 .841 6 .134 
2 
.262 7 .159 .881 7 .232 
DiastolicPre 1 
.202 6 .200 .956 6 .785 
2 
.223 7 .200 .901 7 .338 
SystolicPost 1 
.195 6 .200 .915 6 .470 
2 
.172 7 .200 .934 7 .587 
DiastolicPost 1 
.235 6 .200 .895 6 .344 
2 
.211 7 .200 .875 7 .203 
a. Lilliefors Significance Correction 
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Tests of Normality 
Group 
Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
VO2maxPre 1 
.241 6 .200 .936 6 .629 
2 
.171 7 .200 .980 7 .961 
VO2maxPost 1 
.261 6 .200 .852 6 .162 
2 
.178 7 .200 .956 7 .786 
VO2maxDelta 1 
.196 6 .200 .905 6 .403 
2 
.217 7 .200 .866 7 .170 
RER 1 
.198 6 .200 .948 6 .728 
2 
.229 7 .200 .941 7 .652 
RERPost 1 
.290 6 .125 .840 6 .131 
2 
.172 7 .200 .967 7 .873 
HRPRE 1 
.237 6 .200 .868 6 .217 
2 
.334 7 .018 .831 7 .081 
HRPost 1 
.243 6 .200 .885 6 .293 
2 
.145 7 .200 .980 7 .959 
TTE 1 
.192 6 .200 .905 6 .406 
2 
.186 7 .200 .953 7 .756 
TTEPOST 1 
.174 6 .200 .945 6 .701 
2 
.263 7 .155 .906 7 .366 
Wattage 1 
.195 6 .200 .911 6 .441 
2 
.160 7 .200 .956 7 .788 
WattagePost 1 
.179 6 .200 .944 6 .690 
2 
.278 7 .108 .898 7 .319 
BaseDiamPre 1 
.272 6 .187 .889 6 .311 
2 
.213 7 .200 .952 7 .750 
PeakDiamPre 1 
.312 6 .069 .855 6 .172 
2 
.198 7 .200 .974 7 .928 
FMDPre 1 
.211 6 .200 .955 6 .782 
2 
.130 7 .200 .981 7 .963 
BaseDiamPost 1 
.175 6 .200 .923 6 .525 
2 
.313 7 .036 .845 7 .111 
PeakDiamPost 1 
.190 6 .200 .977 6 .934 
2 
.234 7 .200 .914 7 .422 
FMDPost 1 
.234 6 .200 .849 6 .153 
2 
.186 7 .200 .968 7 .883 
FMDDelta 1 
.257 6 .200 .867 6 .216 
2 
.340 7 .014 .720 7 .006 
a. Lilliefors Significance Correction 
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Tests of Normality 
Group 
Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
FMDPreAdjBase 1 
.272 6 .187 .889 6 .311 
2 
.213 7 .200 .952 7 .750 
FMDPostAdjBase 1 
.272 6 .187 .889 6 .311 
2 
.213 7 .200 .952 7 .750 
FMDAdjDelta 1 
.272 6 .187 .889 6 .311 
2 
.213 7 .200 .952 7 .750 
Calories 1 
.265 6 .200 .869 6 .223 
2 
.164 7 .200 .962 7 .838 
Totalfat 1 
.164 6 .200 .986 6 .976 
2 
.227 7 .200 .927 7 .529 
Satfat 1 
.190 6 .200 .968 6 .879 
2 
.339 7 .015 .780 7 .026 
Sugar 1 
.175 6 .200 .936 6 .629 
2 
.241 7 .200 .854 7 .133 
CHOLpre 1 
.263 6 .200 .941 6 .664 
2 
.150 7 .200 .987 7 .987 
CHOLpost 1 
.270 6 .198 .843 6 .139 
2 
.190 7 .200 .948 7 .708 
CHOLdelta 1 
.218 6 .200 .934 6 .609 
2 
.188 7 .200 .915 7 .432 
GLU2pre 1 
.231 6 .200 .896 6 .353 
2 
.150 7 .200 .943 7 .661 
GLU2post 1 
.203 6 .200 .947 6 .715 
2 
.150 7 .200 .962 7 .837 
GLU2delta 1 
.195 6 .200 .978 6 .943 
2 
.198 7 .200 .895 7 .301 
HDLpre 1 
.272 6 .187 .809 6 .070 
2 
.256 7 .181 .851 7 .125 
HDLpost 1 
.282 6 .147 .877 6 .256 
2 
.183 7 .200 .915 7 .435 
HDLdelta 1 
.256 6 .200 .898 6 .365 
2 
.224 7 .200 .904 7 .354 
LDLpre 1 
.237 6 .200 .863 6 .200 
2 
.137 7 .200 .970 7 .897 
LDLpost 1 
.178 6 .200 .940 6 .656 
2 
.200 7 .200 .920 7 .466 
a. Lilliefors Significance Correction 
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Tests of Normality 
Group 
Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
LDLdelta 1 
.222 6 .200 .867 6 .216 
2 
.162 7 .200 .987 7 .987 
TRIGpre 1 
.319 6 .056 .702 6 .007 
2 
.255 7 .190 .924 7 .504 
TRIGpost 1 
.221 6 .200 .896 6 .352 
2 
.131 7 .200 .971 7 .905 
TRIGdelta 1 
.276 6 .169 .804 6 .064 
2 
.190 7 .200 .955 7 .774 
hsCRPpre 1 
.259 6 .200 .840 6 .131 
2 
.386 7 .002 .590 7 .000 
hsCRPpost 1 
.247 6 .200 .869 6 .223 
2 
.356 7 .008 .667 7 .002 
hsCRPdelta 1 
.325 6 .047 .731 6 .013 
2 
.443 7 .000 .632 7 .001 
NOpre 1 
.175 6 .200 .915 6 .468 
2 
.185 7 .200 .959 7 .811 
NOpost 1 
.165 6 .200 .984 6 .970 
2 
.252 7 .200 .858 7 .144 
NOdelta 1 
.198 6 .200 .932 6 .599 
2 
.144 7 .200 .985 7 .979 
AOXpre 1 
.214 6 .200 .921 6 .510 
2 
.228 7 .200 .885 7 .248 
AOXpost 1 
.253 6 .200 .888 6 .308 
2 
.192 7 .200 .958 7 .804 
a. Lilliefors Significance Correction 
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Change in Body Weight (Exercise vs. Control) 
 
Group Statistics 
 Group N Mean Std. Deviation Std. Error Mean 
WeightDelta 
Exercise 10 -.050000 1.2695098 .4014542 
Control 9 1.691556 2.0192692 .6730897 
 
 
Independent Samples Test 
 Levene's 
Test for 
Equality of 
Variances 
t-test for Equality of Means 
F Sig. t df Sig. 
(2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
WeightDelta 
Equal 
variances 
assumed 
.872 .363 -
2.277 
17 .036 -
1.7415556 
.7649876 -
3.3555382 
-
.1275729 
Equal 
variances 
not 
assumed 
  
-
2.222 
13.217 .044 -
1.7415556 
.7837189 -
3.4318513 
-
.0512599 
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Change in Flow Mediated Dilation (Exercise vs. Control) 
 
Group Statistics 
 Group N Mean Std. Deviation Std. Error Mean 
FMDDelta 
Exercise 9 1.25333 4.274541 1.424847 
Control 9 1.19444 2.913473 .971158 
 
 
Independent Samples Test 
 Levene's 
Test for 
Equality of 
Variances 
t-test for Equality of Means 
F Sig. t df Sig. 
(2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
FMDDelta 
Equal 
variances 
assumed 
1.109 .308 .034 16 .973 .058889 1.724337 -
3.596541 
3.714319 
Equal 
variances 
not 
assumed 
  
.034 14.114 .973 .058889 1.724337 -
3.636655 
3.754433 
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Change in VO2max (Exercise vs. Control) 
 
Group Statistics 
 Group N Mean Std. Deviation Std. Error Mean 
VO2maxDelta 
Exercise 10 .230500 .2089185 .0660658 
Control 9 -.022222 .1054488 .0351496 
 
 
Independent Samples Test 
 Levene's 
Test for 
Equality of 
Variances 
t-test for Equality of Means 
F Sig. t df Sig. 
(2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
VO2maxDelta 
Equal 
variances 
assumed 
2.826 .062 3.267 17 .005 .2527222 .0773490 .0895301 .4159143 
Equal 
variances 
not 
assumed 
  3.377 13.591 .005 .2527222 .0748344 .0917643 .4136802 
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Change in Body Fat Percentage (Exercise vs. Control) 
 
Group Statistics 
 Group N Mean Std. Deviation Std. Error Mean 
BodyFatDelta 
Exercise 9 -.255556 1.4116578 .4705526 
Control 8 1.500000 1.1058287 .3909695 
 
 
Independent Samples Test 
 Levene's 
Test for 
Equality of 
Variances 
t-test for Equality of Means 
F Sig. t df Sig. 
(2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
BodyFatDelta 
Equal 
variances 
assumed 
.843 .373 -
2.827 
15 .013 -
1.7555556 
.6210339 -
3.0792580 
-
.4318531 
Equal 
variances 
not 
assumed 
  
-
2.870 
14.798 .012 -
1.7555556 
.6117817 -
3.0610880 
-
.4500231 
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Change in Total Cholesterol (Exercise vs. Control) 
 
Group Statistics 
 Group N Mean Std. Deviation Std. Error Mean 
CHOLdelta 
Exiercise 10 6.50000 16.372402 5.177408 
Control 9 -4.11111 11.634479 3.878160 
 
 
Independent Samples Test 
 Levene's 
Test for 
Equality of 
Variances 
t-test for Equality of Means 
F Sig. t df Sig. 
(2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
CHOLdelta 
Equal 
variances 
assumed 
.452 .511 1.611 17 .126 10.611111 6.588383 -
3.289162 
24.511384 
Equal 
variances 
not 
assumed 
  1.640 16.197 .120 10.611111 6.468824 -
3.088670 
24.310892 
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Change in Blood Glucose (Exercise vs. Control) 
 
Group Statistics 
 Group N Mean Std. Deviation Std. Error Mean 
GLU2delta 
Exercise 10 -.10000 6.640783 2.100000 
Control 9 1.33333 4.062019 1.354006 
 
 
Independent Samples Test 
 Levene's 
Test for 
Equality of 
Variances 
t-test for Equality of Means 
F Sig. t df Sig. 
(2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
GLU2delta 
Equal 
variances 
assumed 
1.319 .267 -
.559 
17 .583 -1.433333 2.562819 -
6.840408 
3.973741 
Equal 
variances 
not 
assumed 
  
-
.574 
15.102 .575 -1.433333 2.498666 -
6.755979 
3.889312 
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Change in HDL Cholesterol (Exercise vs. Control) 
 
Group Statistics 
 Group N Mean Std. Deviation Std. Error Mean 
HDLdelta 
Exercise 10 4.70000 6.929005 2.191144 
Control 9 -.55556 7.617597 2.539199 
 
 
Independent Samples Test 
 Levene's 
Test for 
Equality of 
Variances 
t-test for Equality of Means 
F Sig. t df Sig. 
(2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
HDLdelta 
Equal 
variances 
assumed 
.047 .830 1.575 17 .134 5.255556 3.336285 -
1.783391 
12.294502 
Equal 
variances 
not 
assumed 
  1.567 16.311 .136 5.255556 3.353900 -
1.843396 
12.354507 
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Change in LDL Cholesterol (Exercise vs. Control) 
 
Group Statistics 
 Group N Mean Std. Deviation Std. Error Mean 
LDLdelta 
Exercise 9 2.60556 12.830132 4.276711 
Control 9 -2.51444 11.104841 3.701614 
 
 
Independent Samples Test 
 Levene's 
Test for 
Equality of 
Variances 
t-test for Equality of Means 
F Sig. t df Sig. 
(2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
LDLdelta 
Equal 
variances 
assumed 
.734 .404 .905 16 .379 5.120000 5.656165 -
6.870533 
17.110533 
Equal 
variances 
not 
assumed 
  
.905 15.678 .379 5.120000 5.656165 -
6.890609 
17.130609 
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Change in Triglycerides (Exercise vs. Control) 
 
Group Statistics 
 Group N Mean Std. Deviation Std. Error Mean 
TRIGdelta 
Exercise 7 -16.02857 29.726504 11.235562 
Control 9 15.07778 24.139614 8.046538 
 
 
Independent Samples Test 
 Levene's 
Test for 
Equality of 
Variances 
t-test for Equality of Means 
F Sig. t df Sig. 
(2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
TRIGdelta 
Equal 
variances 
assumed 
.011 .917 -
2.314 
14 .036 -
31.106349 
13.444272 -
59.941444 
-
2.271254 
Equal 
variances 
not 
assumed 
  
-
2.251 
11.470 .045 -
31.106349 
13.819719 -
61.371937 
-.840762 
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Change in High Sensitivity C-reactive Protein (Exercise vs. Control) 
 
Group Statistics 
 Group N Mean Std. Deviation Std. Error Mean 
hsCRPdelta 
Exercise 9 -.03444 .627477 .209159 
Control 9 .77111 2.560852 .853617 
 
 
Independent Samples Test 
 Levene's 
Test for 
Equality of 
Variances 
t-test for Equality of Means 
F Sig. t df Sig. 
(2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
hsCRPdelta 
Equal 
variances 
assumed 
2.467 .136 -
.917 
16 .373 -.805556 .878869 -
2.668674 
1.057562 
Equal 
variances 
not 
assumed 
  
-
.917 
8.957 .383 -.805556 .878869 -
2.795145 
1.184034 
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Change in Nitric Oxide Availability (Exercise vs. Control) 
 
Group Statistics 
 Group N Mean Std. Deviation Std. Error Mean 
NOdelta 
Exercise 9 4.33269 8.769026 2.923009 
Control 9 -4.29953 3.398838 1.132946 
 
 
Independent Samples Test 
 Levene's 
Test for 
Equality of 
Variances 
t-test for Equality of Means 
F Sig. t df Sig. 
(2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
NOdelta 
Equal 
variances 
assumed 
2.858 .110 2.754 16 .014 8.632214 3.134892 1.986541 15.277888 
Equal 
variances 
not 
assumed 
  2.754 10.351 .020 8.632214 3.134892 1.679181 15.585247 
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Change in Antioxidant Capacity (Exercise vs. Control) 
 
Group Statistics 
 Group N Mean Std. Deviation Std. Error Mean 
AOXdelta 
Exercise 9 .0573 .44769 .14923 
Control 9 .1805 .32414 .10805 
 
 
Independent Samples Test 
 Levene's Test 
for Equality of 
Variances 
t-test for Equality of Means 
F Sig. t df Sig. 
(2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% 
Confidence 
Interval of the 
Difference 
Lower Upper 
AOXdelta 
Equal 
variances 
assumed 
.024 .880 -
.669 
16 .513 -.12320 .18424 -
.51377 
.26736 
Equal 
variances not 
assumed 
  
-
.669 
14.579 .514 -.12320 .18424 -
.51689 
.27048 
 
  
135 
 
APPENDIX H 
 
SUBJECT DATA 
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Group Subject Age Height WeightPre WeightPost WeightDelt BMI 
1 2 24 183 67.78 67.92 0.14 20.24 
1 3 21 176 75.76 74.39 -1.38 24.46 
1 6 23 176 76.61 77.64 1.02 24.73 
1 7 22 168 64.15 61.18 -2.97 22.73 
1 11 25 173.9 73.97 74.79 0.82 24.46 
1 16 28 175.5 69.11 69.17 0.05 22.44 
1 17 19 172 68.40 68.52 0.12 23.12 
1 18 22 171 85.71 86.62 0.92 29.31 
1 20 23 177.1 86.90 86.61 -0.29 27.71 
1 21 24 187.8 74.52 75.58 1.06 21.13 
2 1 29 179 87.80 89.40 1.60 27.40 
2 4 24 181 83.41 88.56 5.16 25.46 
2 5 25 181 79.39 82.46 3.07 24.23 
2 8 20 181.5 71.37 73.28 1.91 21.67 
2 9 26 181 123.63 122.36 -1.27 37.74 
2 10 19 164.25 55.21 56.67 1.47 20.46 
2 12 30 179.2 60.51 63.25 2.74 18.84 
2 14 22 170.5 55.60 54.34 -1.26 19.13 
2 15 30 174.5 92.72 94.53 1.81 30.45 
          AVE G1 23.100 176.030 74.290 74.240 -0.050 24.032 
GROUP SD G1 2.424 5.765 7.482 8.090 1.270 2.791 
DATA AVE G2 25.000 176.883 78.846 80.538 1.692 25.042 
  SD G2 4.153 6.000 21.767 21.502 2.019 6.150 
        
TOTALS 
AVE 
AGE 24.000 176.434 76.448 77.223 0.775 24.510 
  SD AGE 3.399 5.728 15.622 15.768 1.848 4.580 
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Group Subject BodyFatPre BodyFatPost BodyFatDelta FatMassPre FatMassPost 
1 2 5.1 6 0.90 3.44 4.084 
1 3 11.3 10.8 -0.50 8.58 8.025 
1 6 24.9 23.9 -1.00 19.05 18.533 
1 7 #NULL! #NULL! #NULL! #NULL! #NULL! 
1 11 20.5 22.6 2.10 15.16 16.891 
1 16 10.9 10.2 -0.70 7.57 7.038 
1 17 12.2 10.2 -2.00 8.32 6.971 
1 18 24.6 25.4 0.80 21.11 22.009 
1 20 31.8 29.6 -2.20 27.81 25.614 
1 21 15.3 15.6 0.30 11.40 11.76 
2 1 23 24.5 1.50 20.18 21.895 
2 4 27.8 30.2 2.40 23.22 26.719 
2 5 17.6 19.5 1.90 14.00 15.88 
2 8 14.8 16.3 1.50 10.53 11.633 
2 9 50.5 50.1 -0.40 62.48 61.331 
2 10 9.7 9.8 0.10 5.35 5.476 
2 12 12.3 14.7 2.40 7.44 9.301 
2 14 #NULL! #NULL! #NULL! #NULL! #NULL! 
2 15 28 30.6 2.60 25.99 28.919 
         AVE G1 17.400 17.144 -0.256 13.604 13.436 
GROUP SD G1 8.568 8.381 1.412 7.810 7.599 
DATA AVE G2 22.963 24.463 1.500 21.146 22.644 
  SD G2 13.050 12.702 1.106 18.277 17.700 
       
TOTALS 
AVE 
AGE 20.018 20.588 0.571 17.153 17.769 
  SD AGE 10.927 10.949 1.532 13.846 13.725 
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Group Subject FatMassDelta SystolicPre DiastolicPre SystolicPost DiastolicPost 
1 2 0.65 113 78 118 78 
1 3 -0.55 120 75 115 72 
1 6 -0.52 132 63 122 68 
1 7 #NULL! 112 66 125 76 
1 11 1.73 117 77 117 66 
1 16 -0.53 117 70 130 78 
1 17 -1.35 119 82 113 70 
1 18 0.90 133 80 131 78 
1 20 -2.19 132 90 137 90 
1 21 0.36 125 86 129 90 
2 1 1.72 135 92 143 94 
2 4 3.50 127 74 122 85 
2 5 1.88 123 81 117 73 
2 8 1.11 114 65 115 65 
2 9 -1.15 126 68 122 69 
2 10 0.13 113 68 113 67 
2 12 1.86 129 84 127 77 
2 14 #NULL! 118 66 112 63 
2 15 2.93 131 85 130 94 
         AVE G1 -0.167 122.000 76.700 123.700 76.600 
GROUP SD G1 1.203 7.986 8.525 7.959 8.276 
DATA AVE G2 1.498 124.000 75.889 122.333 76.333 
  SD G2 1.483 7.632 9.867 9.899 12.031 
       
TOTALS 
AVE 
AGE 0.616 122.947 76.316 123.053 76.474 
  SD AGE 1.556 7.670 8.932 8.702 9.930 
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Group Subject VO2Pre VO2Post VO2Delta RERpre RERPost HRPRE HRPost 
1 2 2.99 3.64 0.65 1.2 1.22 192 191 
1 3 2.8 3.28 0.48 1.24 1.24 198 196 
1 6 2.94 3.01 0.07 1.25 1.24 195 191 
1 7 3.59 3.63 0.04 1.3 1.22 190 193 
1 11 3.19 3.32 0.13 1.25 1.23 181 173 
1 16 3.51 3.62 0.11 1.2 1.22 177 167 
1 17 2.98 3.05 0.07 1.16 1.19 174 182 
1 18 3.11 3.3 0.19 1.14 1.21 179 188 
1 20 2.63 3.05 0.42 1.28 1.24 176 169 
1 21 3.14 3.29 0.15 1.23 1.23 188 182 
2 1 2.9 2.97 0.07 1.15 1.23 183 181 
2 4 2.66 2.67 0.01 1.13 1.21 183 174 
2 5 2.34 2.34 0 1.22 1.29 178 178 
2 8 2.88 2.69 -0.19 1.33 1.24 184 176 
2 9 2.48 2.55 0.07 1.2 1.23 165 166 
2 10 2.99 2.81 -0.18 1.21 1.24 188 191 
2 12 2.14 2.07 -0.07 1.08 1.25 175 158 
2 14 2.14 2.13 -0.01 1.13 1.23 166 183 
2 15 3.4 3.5 0.1 1.19 1.22 186 186 
           AVE G1 3.088 3.319 0.231 1.225 1.224 185.000 183.200 
GROUP SD G1 0.294 0.243 0.209 0.050 0.016 8.628 10.412 
DATA AVE G2 2.659 2.637 -0.022 1.182 1.238 178.667 177.000 
  SD G2 0.424 0.442 0.105 0.072 0.023 8.426 10.137 
         
TOTALS 
AVE 
AGE 2.885 2.996 0.111 1.205 1.231 182.000 180.263 
  SD AGE 0.414 0.489 0.209 0.064 0.020 8.907 10.487 
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Group Subject TTEpre TTEPOST Wattage WattagePost PkDiamPre PkDiamPost 
1 2 8:44:00 9:13:00 301 316 0.36 0.38 
1 3 5:54:00 6:52:00 219 247 0.40 0.44 
1 6 7:20:00 7:38:00 256 271 0.40 0.40 
1 7 9:05:00 9:35:00 316 331 0.40 0.44 
1 11 6:50:00 7:45:00 249 271 0.45 0.45 
1 16 8:53:00 8:36:00 308 301 0.41 0.45 
1 17 6:26:00 7:57:00 234 279 0.40 0.40 
1 18 7:21:00 8:15:00 260 294 0.46 0.50 
1 20 6:02:00 6:46:00 226 249 0.47 0.45 
1 21 8:25:00 9:05:00 294 315 0.40 0.42 
2 1 7:26:00 8:53:00 264 309 0.43 0.45 
2 4 5:41:00 5:28:00 211 204 0.38 0.41 
2 5 6:22:00 6:08:00 234 229 0.43 0.50 
2 8 6:30:00 5:11:00 241 196 0.37 0.41 
2 9 4:38:00 5:17:00 181 203 0.42 0.39 
2 10 7:26:00 7:23:00 263 263 0.32 0.32 
2 12 4:03:00 4:05:00 167 167 0.42 0.42 
2 14 4:29:00 4:27:00 179 175 0.32 0.35 
2 15 8:27:00 8:22:00 303 294 0.47 0.46 
          AVE G1 0.312 0.340 266.300 287.400 0.415 0.432 
GROUP SD G1 0.050 0.040 35.793 28.722 0.035 0.034 
DATA AVE G2 0.255 0.256 227.000 226.667 0.397 0.411 
  SD G2 0.063 0.071 46.046 51.091 0.054 0.055 
        TOTAL
S AVE AGE 0.285 0.300 247.684 258.632 0.406 0.422 
  SD AGE 0.063 0.070 44.602 50.431 0.045 0.046 
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Group Subject PeakDELTA BaseDiamPre BaseDiamPost BaselineDELTA FMDPre 
1 2 0.02 0.36 0.37 0.01 0.84 
1 3 0.04 0.40 0.42 0.02 -0.50 
1 6 0.01 0.38 0.39 0.02 5.60 
1 7 0.04 0.38 0.43 0.05 5.26 
1 11 -0.01 0.43 0.44 0.01 5.36 
1 16 0.04 0.41 0.43 0.03 1.23 
1 17 0.00 0.37 0.38 0.01 8.15 
1 18 0.03 0.44 0.48 0.04 5.94 
1 20 -0.02 0.42 0.44 0.01 10.64 
1 21 0.01 0.37 0.40 0.03 9.78 
2 1 0.01 0.40 0.41 0.01 7.96 
2 4 0.03 0.36 0.38 0.03 7.30 
2 5 0.06 0.39 0.45 0.07 11.57 
2 8 0.04 0.38 0.40 0.02 -1.59 
2 9 -0.03 0.39 0.34 -0.05 8.29 
2 10 0.00 0.31 0.32 0.02 4.26 
2 12 0.00 0.40 0.39 -0.01 6.80 
2 14 0.03 0.31 0.32 0.00 0.96 
2 15 -0.01 0.45 0.44 0.00 6.28 
         AVE G1 0.02 0.39 0.42 0.02 5.23 
GROUP SD G1 0.02274887 0.028795254 0.032380378 0.013543756 3.759519 
DATA AVE G2 0.01 0.37 0.38 0.01 5.76 
  SD G2 0.02950894 0.044269377 0.050059964 0.030384115 4.000835 
       TOTALS AVE AGE 0.016 0.385 0.401 0.016 5.481 
  SD AGE 0.025 0.037 0.044 0.023 3.775 
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Group Subject FMDPost FMDDelta 
Diet 
Intake Calories Totalfat Satfat Sugar 
1 2 2.73 1.89 2897 11640 702 324 546 
1 3 4.49 4.99 2319 11580 720 324 462 
1 6 2.80 -2.80 2201 11940 756 345 522 
1 7 3.50 -1.77 2604 11640 702 318 540 
1 11 2.53 -2.83 2130 11850 672 303 531 
1 16 4.61 3.37 2810 11400 720 324 456 
1 17 3.94 -4.22 2920 12000 669 303 597 
1 18 4.42 -1.52 1910 11550 627 279 579 
1 20 2.99 -7.65 2245 11460 672 300 564 
1 21 5.82 -3.96 2518 11340 642 291 564 
2 1 9.05 1.09 2854 11850 681 309 519 
2 4 7.05 -0.25 2705 11880 618 264 552 
2 5 9.69 -1.88 2690 11520 696 312 534 
2 8   1.59 2505 11580 702 309 441 
2 9 14.54 6.25 2412 11760 666 303 585 
2 10 -0.63 -4.89 2752 11760 714 327 534 
2 12 7.65 0.85 2580 11670 684 309 549 
2 14 10.76 9.80 1985 11520 687 306 498 
2 15 4.52 -1.75 2008 11730 669 306 546 
           AVE G1 3.78 -1.45 2455.400 11640.000 688.200 311.100 536.100 
GROUP SD G1 1.06112 3.831513 348.576 224.944 39.120 19.393 46.369 
DATA AVE G2 7.83 1.20 2499.000 11696.667 679.667 305.000 528.667 
  SD G2 4.49767 4.431717 313.926 133.697 27.663 16.837 40.632 
         
TOTALS 
AVE 
AGE 5.581 -0.193 2476.053 11666.842 684.158 308.211 532.579 
  SD AGE 3.634 4.233 324.118 184.633 33.533 17.996 42.701 
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Group Subject CHOLpre CHOLpost CHOLdelta HDLpre HDLpost HDLdelta 
1 2 129 121 -8 43 43 0 
1 3 108 110 2 36 39 3 
1 6 202 185 -17 38 43 5 
1 7           0 
1 11 171 199 28 39 47 8 
1 16 148 153 5 49 56 7 
1 17 140 178 38 64 85 21 
1 18 138 136 -2 68 75 7 
1 20 172 186 14 67 63 -4 
1 21 171 176 5 53 53 0 
2 1 207 194 -13 61 56 -5 
2 4 150 130 -20 38 54 16 
2 5 198 198 0 58 49 -9 
2 8 75 81 6 40 39 -1 
2 9 139 143 4 49 46 -3 
2 10 116 113 -3 42 43 1 
2 12 158 136 -22 70 61 -9 
2 14 118 118 0 55 57 2 
2 15 176 187 11 37 40 3 
       
0 
  AVE G1 153.222 160.444 7.222 50.778 56.000 5.222222 
GROUP SD G1 28.350 31.714 17.196 12.863 15.684 2.821866 
DATA AVE G2 145.125 139.125 -6.000 51.625 50.625 -1 
  SD G2 43.676 39.808 10.863 11.326 7.615 -3.71094 
       
0 
TOTALS AVE AGE 150.889 152.444 1.556 50.389 52.722 2.333333 
  SD AGE 34.918 36.241 15.390 11.917 12.527 0.609643 
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Group Subject LDLpre LDLpost LDLdelta TRIGpre TRIGpost TRIGdelta 
1 2 82.21 75.89 -6.32 57.43 52.75 -4.68 
1 3 64.91 64.09 -0.82 44.73 56.85 12.12 
1 6 146.83 132.47 -14.36 201.98 123.24 -78.74 
1 7             
1 11 110.97 128.37 17.4 222.84 269.49 46.65 
1 16 80.11 75.54 -4.57 137.1 247.14 110.04 
1 17 70.91 90.44 19.53 59.5 38.69 -20.81 
1 18 59.24 50.11 -9.13 87.98 80.42 -7.56 
1 20 103.99 122.16 18.17 62.72 65.48 2.76 
1 21 108.3 111.85 3.55 131.96 116.67 -15.29 
2 1 135.9 132.91 -2.99 75.28 93.21 17.93 
2 4 94.1 70.44 -23.66 114.46 86.79 -27.67 
2 5 121.66 127 5.34 143.93 191.28 47.35 
2 8 26.25 26.84 0.59 68.68 115.27 46.59 
2 9 79.59 84.95 5.36 95.86 106.32 10.46 
2 10 64.81 60.05 -4.76 75.89 71.15 -4.74 
2 12 83.29 71.73 -11.56 58.16 48.77 -9.39 
2 14 55.31 49.35 -5.96 55.95 86.91 30.96 
2 15 122.87 137.88 15.01 128.53 120.97 -7.56 
          AVE G1 91.941 94.547 2.606 111.804 116.748 4.943 
GROUP SD G1 27.984 30.151 12.830 65.836 85.220 51.436 
DATA AVE G2 82.614 77.909 -4.705 86.026 99.963 13.936 
  SD G2 35.345 36.491 9.570 30.374 42.180 27.057 
        
TOTALS 
AVE 
AGE 89.514 89.559 0.046 101.277 109.522 8.246 
  SD AGE 31.207 34.503 11.935 51.297 65.027 39.777 
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Group Subject hsCRPpre hsCRPpost hsCRPdelta GLU2pre GLU2post GLU2delta 
1 2 0.17 0.35 0.18 107 94 -13 
1 3 2.7 1.1 -1.6 83 91 8 
1 6 0.58 0.33 -0.25 87 84 -3 
1 7           0 
1 11 0.11 0.52 0.41 91 91 0 
1 16 0.15 0.61 0.46 82 91 9 
1 17 1.34 1.33 -0.01 80 82 2 
1 18 0.16 0.43 0.27 76 73 -3 
1 20 0.72 0.72 0 90 84 -6 
1 21 0.32 0.55 0.23 88 93 5 
2 1 0.48 0.7 0.22 89 92 3 
2 4 0.41 0.29 -0.12 96 94 -2 
2 5 1.07 0.96 -0.11 93 89 -4 
2 8 0.31 0.51 0.2 91 99 8 
2 9 4.26 2.81 -1.45 99 106 7 
2 10 0.13 0.45 0.32 88 89 1 
2 12 0.37 7.81 7.44 80 78 -2 
2 14 0.15 0.52 0.37 94 94 0 
2 15 0.87 0.94 0.07 100 99 -1 
          AVE G1 0.694 0.660 -0.034 87.111 87.000 -0.111 
GROUP SD G1 0.851 0.342 0.627 8.923 6.819 7.044 
DATA AVE G2 0.898 1.756 0.859 91.250 92.625 1.375 
  SD G2 1.390 2.576 2.723 5.800 8.141 4.340 
        TOTALS AVE 0.794 1.163 0.368 89.667 90.167 0.474 
  STDEV 1.071 1.758 1.856 7.889 7.868 5.481 
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Group Subject Insulinpre Insulinpost InsulinDelta HOMApre HOMApost HOMAdelta 
1 2 8.401 7.166 -1.235 2.220 1.663 -0.556 
1 3 7.323 7.303 -0.02 1.501 1.641 0.140 
1 6 15.142 12.585 -2.557 3.253 2.610 -0.643 
1 7     0 0.000 0.000 0.000 
1 11 14.295 10.285 -4.01 3.212 2.311 -0.901 
1 16 13.585 11.923 -1.662 2.751 2.679 -0.072 
1 17 7.185 7.093 -0.092 1.419 1.436 0.017 
1 18 16.629 16.011 -0.618 3.121 2.886 -0.235 
1 20 8.822 7.95 -0.872 1.960 1.649 -0.312 
1 21 8.893 5.156 -3.737 1.932 1.184 -0.748 
2 1 7.152 11.367 4.215 1.572 2.582 1.010 
2 4 7.95 8.638 0.688 1.884 2.005 0.120 
2 5 5.469 5.434 -0.035 1.256 1.194 -0.062 
2 8 12.921 23.002 10.081 2.903 5.623 2.719 
2 9 10.274 18.844 8.57 2.511 4.932 2.421 
2 10 12.55 11.944 -0.606 2.727 2.625 -0.102 
2 12 6.682 6.42 -0.262 1.320 1.236 -0.083 
2 14 10.52 6.95 -3.57 2.442 1.613 -0.829 
2 15 13.2 11.95 -1.25 3.259 2.921 -0.338 
          AVE G1 11.142 9.497 -1.645 2.374 2.007 -0.368 
GROUP SD G1 3.712 3.459 1.486 0.728 0.619 0.363 
DATA AVE G2 9.190 11.575 2.385 2.077 2.726 0.649 
  SD G2 2.777 6.301 4.796 0.651 1.674 1.289 
        TOTALS AVE 10.389 10.557 0.159 2.171 2.252 0.081 
  STDEV 3.332 4.814 3.724 0.867 1.303 0.979 
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Group Subject Nopre Nopost Nodelta Aoxpre Aoxpost Aoxdelta 
1 2 1.61 2.17 0.56 2.18 2.13 -0.05 
1 3 1.05 0.56 -0.48 2.05 2.16 0.11 
1 6 3.14 1.64 -1.49 2.32 2.68 0.36 
1 7             
1 11 26.16 51.87 25.71 2.60 2.66 0.06 
1 16 16.76 27.21 10.45 3.22 2.66 -0.56 
1 17 3.47 2.88 -0.60 2.77 2.46 -0.31 
1 18 2.20 3.06 0.86 2.71 2.68 -0.03 
1 20 0.90 3.92 3.02 2.36 3.40 1.03 
1 21 8.55 9.52 0.97 3.19 3.10 -0.09 
2 1 8.18 1.38 -6.79 1.60 1.97 0.37 
2 4 4.22 2.58 -1.64 2.41 2.18 -0.23 
2 5 10.49 2.54 -7.95 2.38 2.26 -0.12 
2 8 11.23 1.53 -9.70 1.71 2.27 0.56 
2 9 6.01 1.57 -4.44 1.91 2.24 0.33 
2 10 0.97 2.35 1.38 2.35 2.65 0.30 
2 12 4.22 1.79 -2.43 2.36 2.43 0.06 
2 14 4.85 1.01 -3.84 2.19 1.96 -0.23 
2 15 4.93 1.64 -3.28 2.15 2.74 0.59 
          AVE G1 7.092 11.425 4.333 2.601 2.658 0.057 
GROUP SD G1 8.780 17.274 8.769 0.417 0.404 0.448 
DATA AVE G2 6.272 1.845 -4.426 2.115 2.244 0.129 
  SD G2 3.477 0.581 3.618 0.328 0.225 0.304 
        TOTALS AVE 6.607 6.624 0.017 2.360 2.479 0.119 
  STDEV 6.450 12.844 7.834 0.434 0.380 0.384 
 
